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Chapter 1 
 
 
 
Introduction And Outline Of The Thesis 
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Introduction 
Tuberculosis is the infection caused by Mycobacterium tuberculosis, a slowly growing 
acid-fast-staining bacillus.  Tuberculosis is transmitted through the airborne route from 
contagious cases to susceptible contacts; most individuals who are infected however do not 
develop clinical disease.  Malnutrition and immunosuppressive disorders such as human 
immunodeficiency virus (HIV) infection increase the risk of developing clinical disease (Figure 
1).  Despite effective antituberculous chemotherapy, tuberculosis is associated with wasting and 
high mortality.  The association of poor nutrition with tuberculosis has long been evident, as 
older terms were used for tuberculosis such as the Greek term “phthisis” or “to waste away”. In 
the developing world, the word “slim disease” is used for both tuberculosis and HIV infection 
interchangeably. 
 
Public Health Importance  
About one third of the world’s population is infected with Mycobacterium tuberculosis, 
representing great numbers of individuals at risk for development of disease. Half or more of 
adults in sub-Saharan Africa, the Indian subcontinent, and Southeast Asia, have latent 
tuberculosis infection. Each year there are 8 million new cases and 3 million deaths due to 
tuberculosis, of which the majority occur in resource-poor countries.1  The rates of concurrent 
HIV and tuberculosis are increasing worldwide, and despite chemotherapy, mortality rates 
remain high.  In many least developed countries, where tuberculosis and HIV co-infection occur 
most, anti-retroviral medications is still largely unavailable.  Tuberculosis is responsible for 
about one-quarter of all preventable deaths in developing countries, and many of these deaths are 
associated with underlying HIV infection.2 
 
Clinical and Laboratory Diagnosis of Tuberculosis 
Active tuberculosis, the form of disease that disturbs normal host physiology to produce 
symptoms, is generally classified as either pulmonary or extra-pulmonary disease.  Pulmonary 
disease is the most common form of active tuberculosis, accounting for approximately 80% of 
cases.  Cough is the most common symptom of pulmonary tuberculosis, occurring in over 95 % 
of cases.  The cough is usually chronic, lasting more than one month, and it is most often 
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productive of sputum.  Occasionally hemoptysis (coughing up blood), dyspnea (shortness of 
breath), and chest pain develop.  Other symptoms include fevers, night sweats, and weight loss.  
The physical examination for tuberculosis is non-specific.  The chest radiograph is often used to 
confirm the presence of pulmonary lesions and assess the extent of disease. The diagnosis of 
tuberculosis is based on the clinical syndrome and the identification of M. tuberculosis in 
appropriate specimens taken from the patient. Staining techniques (such as Ziehl Neelsen and 
fluorescent staining) are the most widely used methods, as they are inexpensive, readily 
available, and easily performed.  Culture of M. tuberculosis is more laborious and expensive, but 
important for epidemiological reasons and determination of susceptibility to antimycobacterial 
drugs. Newer techniques using molecular tools are still largely beyond the reach of developing 
countries. 
 
 
Figure 1. Model for tuberculosis infection and common risk factors. Adapted from Whalen. 
(Whalen 2001) 
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Risk Factors and Magnitude of HIV Co-infection 
 
The risk for tuberculosis infection relates to the probability of contact with an infected 
case, and the risk for developing disease after infection relates to the competence of the host 
immune response in suppressing the infection.  Figure 1 shows common risk factors for 
tuberculosis infection and disease. Once infected, an individual has a 10% lifetime risk of 
developing active tuberculosis.2  For people co-infected with HIV, the lifetime risk of developing 
disease has been estimated at about 60%.3  Common conditions associated with the risk of 
developing active tuberculosis are conditions that affect host defense against mycobacteria (e.g. 
HIV infection and malnutrition).   
HIV infection presents the greatest known risk for the development of both progressive 
primary disease and reactivation tuberculosis.  In sub-Saharan Africa, HIV infection is now 
strongly associated with tuberculosis. In 1989, already 52% of tuberculosis patients were 
reported HIV-positive in a rural hospital in Malawi.4  In 1993-1994 in a central hospital in 
Malawi, 75% of tuberculosis patients were found HIV-positive.5 
 
Malnutrition 
Malnutrition has long been recognized among individuals with tuberculosis. In Epidemics 
III of the Hippocratic corpus from the fifth century, B.C., a clinical description was given 
consistent with pulmonary tuberculosis.  “Phthisis,” “tabes,” and “marasmus” were used to 
describe diseases characterized by emaciation, including tuberculosis. These terms are close in 
suggesting wasting away, weakness, and decay. In the 18th and 19th centuries, tuberculosis 
became known as “consumption”.  Recently, in the developing world, the word “slim disease” 
has been applied for both tuberculosis and HIV infection interchangeably, because of the wasting 
effects of the disease.  Uncertainty remains surrounding the mechanisms as well as the effect of 
this wasting syndrome.   
 
Tuberculosis, HIV infection and Malnutrition 
 
The association between tuberculosis and malnutrition has long been accepted; 
malnutrition predisposes individuals to the development of clinical disease, and tuberculosis 
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contributes to malnutrition. Infection leads to malnutrition through loss of appetite, loss of 
nutrients, changes in metabolism and malabsorption, and changes in feeding practices. (Figure 2)  
In addition, protein-energy malnutrition and deficiencies in micronutrients such as iron, vitamin 
A and zinc are known to affect immunity unfavorably 6-9, contributing to the increase in 
incidence, severity and duration of disease. Iron and other nutrient deficiencies, together with 
chronic disease such as tuberculosis and HIV infection, may cause anemia. Therefore anemia may 
perhaps be seen as both an outcome and marker of malnutrition.  
Co-infection of HIV and tuberculosis introduces an extra dimension to the pathophysiology of 
malnutrition, worsening the malnutrition seen in tuberculosis or HIV infection alone.10  
A combination of HIV and tuberculosis with malnutrition may therefore represent “triple 
trouble.” 
 
 
Figure 2. Infection /malnutrition cycle. Adapted from Tomkins and Watson 1998.  
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Although wasting or malnutrition seems a fundamental sign of tuberculosis in both HIV-
positive and HIV-negative patients, and a major determinant of disease severity and outcome, the 
pathogenesis of malnutrition and/or wasting has not yet been clarified.  It is likely that several 
mechanisms contribute to weight loss by affecting energy intake, raising energy expenditure, 
accelering muscle degradation and inducing changes in lipid, carbohydrate and protein 
metabolism. At a molecular level many enzymes, mediators and receptors are involved in these 
processes, including inflammatory cytokines and the fat derived hormone leptin.  It is unclear 
however to what extent these different components contribute to tuberculosis-associated wasting. 
Before one tries to approach these pathogenetic mechanisms in a direct fashion, more 
information is needed on the nutritional status of patients with tuberculosis with and without 
HIV-co-infection.  Increased understanding of the etiology of tuberculosis-associated wasting 
may help to provide new information about the pathophysiology of this common and serious 
infection and may help to design new intervention strategies.  
 
Study Site   
 
The studies described in this thesis are part of a large and still ongoing randomized, 
double-blind, placebo controlled micronutrient supplementation trial in Malawi. The specific aim 
of this clinical trial is to determine whether a daily multivitamin supplement can reduce 
morbidity and mortality in adults with tuberculosis and HIV infection. The rationale for 
evaluating this low cost intervention was based on data that suggest that adults with HIV/AIDS 
and adults with pulmonary tuberculosis are at high risk of multiple micronutrient deficiencies.  
Such deficiencies, associated with immune suppression, altered nutrient metabolism, anemia, 
impaired growth, and increased oxidative stress, may ultimately result in increased morbidity 
and mortality. The main outcome measure of the ongoing trial is mortality.  Secondary outcome 
measures are body composition assessed by bioelectrical impedance analysis (BIA) and 
anthropometry, relapse rate of pulmonary tuberculosis as indicated by sputum relapse, 
progression of HIV as assessed by plasma HIV load, and biochemical indicators of nutritional 
status and anemia.  
The participants enrolled in the trial receive either a multivitamin (vitamins and minerals) or 
placebo for twenty-four months, beginning with the commencement of tuberculosis 
chemotherapy.  The study population is drawn from the Zomba District, and participants are 
followed at the Johns Hopkins/Malawi College of Medicine Project study clinic at Zomba 
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Central Hospital.  HIV-negative adults with pulmonary tuberculosis were included in the 
protocol to mask the HIV status of the participants to the community and to reduce 
stigmatization.  
Baseline data, regarding socio-demographic information, plasma HIV-load, body composition,  
chest radiography and biochemical indicators of nutritional status and anemia, of the first 
approximately 800 participants recruited between July 1999 and April 2003 were used in the 
studies presented in this thesis.  
 
Figure 3. 
 
The study site is situated in Zomba, in the Southern region of Malawi (Figure 3).  Malawi 
is situated in South East Africa and is bordered by Tanzania in the north, Zambia in the west and 
Mozambique in the south and east. The climate is tropical continental and most people depend 
on farming for income and food.  
According to the last official population census carried out in 1998, the total population was 9.9 
million. 46% of the total population was under the age of 15.  Zomba district counted 550 
MALAWI  
Statistics 2000, WHO: 
 
Total population:    11.5 million 
GDP per capita (Intl $)*:    500 
Life expectancy at birth m/f (years):  36/37 
Healthy life expectancy at birth m/f (years):  29/31 
Child mortality m/f (per 1000):  261/240 
Adult mortality m/f (per 1000):  695/636 
Total health expenditure as % of GDP:  7.6 
 
* Intl $: a common currency unit that takes into account differences 
in the relative purchasing power of various currencies. 
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thousand inhabitants. The annual population growth has been estimated at 2%. Of the total 
population in Malawi, 86% lived in rural areas. Literacy rates among males and females stood at 
64 and 51 percent for males and females respectively. Statistics and health indicators (see figure 
3) indicate Malawi as one of the poorest countries in Sub-Saharan Africa, and in fact worldwide. 
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OUTLINE OF THE THESIS 
Below, a brief outline of the thesis is given. For each chapter the subject of the research 
described in the paper is specified.  
In Chapter 2 we asked the question which nutritional indicators are important in 
tuberculosis. Therefore we reviewed the current state of knowledge regarding the nutritional 
status of patients co-infected with tuberculosis and HIV, describing changes in nutrition 
indicators during tuberculosis chemotherapy, and examining the relationship between nutrition 
and clinical outcomes. 
In Chapter 3 we dealt with the question whether there is a relationship between 
malnutrition and the severity of lung damage in tuberculosis. This was approached by relating 
the extent of malnutrition to the extent of lung disease in adults with pulmonary tuberculosis 
with and without HIV infection. Chest radiographs, anthropometric and BIA measurements were 
obtained. Lung disease in chest radiographs was categorized according to a conventional 
classification system.  
In Chapter 4 we tested the hypothesis that micronutrient malnutrition is associated with 
wasting and higher plasma HIV load in adults with tuberculosis.  We focused on associations 
between anthropometry, plasma HIV load and plasma micronutrient concentrations (retinol, α-
tocopherol, carotenoids, zinc, and selenium) in adults with pulmonary tuberculosis with and 
without HIV infection.  We examined the risk of micronutrient deficiencies at different severity 
levels of wasting. 
In Chapter 5 we attempted to answer the question to what extent iron deficiency, 
micronutrient malnutrition and infection contribute to anemia in pulmonary tuberculosis. This 
was approached by relating hemoglobin concentrations to erythropoietin, ferritin, interleukin-6 
(IL-6), HIV load and plasma micronutrient concentrations in adults with pulmonary tuberculosis. 
In Chapter 6 we dealt with the question whether the fat derived hormone leptin plays a 
role in tuberculosis-associated wasting. We explored the relationships between plasma leptin 
concentrations and self-reported loss of appetite, body composition, IL-6 and HIV load in adults 
with pulmonary tuberculosis with and without HIV infection. 
In Chapter 7 the main findings of the investigations presented are discussed, and 
conclusions are drawn with implications for intervention strategies and future research.
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Abstract 
Worldwide, the number of individuals who are co-infected with human immunodeficiency virus 
(HIV) and tuberculosis is increasing greatly. The “triple trouble” of HIV and tuberculosis 
infection and malnutrition may put those infected at greater risk than those with any of the three 
conditions alone. Further investigation is needed to evaluate the prophylactic and therapeutic 
potential of nutritional interventions for co-infection with HIV and tuberculosis. 
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Introduction 
Tuberculosis, an infection caused by Mycobacterium tuberculosis, is the leading cause of 
infectious mortality worldwide, accounting for three million deaths per year.1 The link between 
tuberculosis and malnutrition has long been recognized; malnutrition may predispose people to 
the development of clinical disease, and tuberculosis can contribute to malnutrition.2 Nearly one 
third of the world’s population––1.8 billion people––are infected with Mycobacterium 
tuberculosis, and the majority of these individuals live in developing countries where the 
prevalence of human immunodeficiency virus (HIV) infection is also high.3,4 The risk of 
developing clinical tuberculosis is greater among individuals with immunosuppression, which 
explains the increase in the prevalence of tuberculosis in association with HIV infection. In some 
countries in sub-Saharan Africa, the HIV seroprevalence rate among tuberculosis patients is 
reportedly more than 75%.5–7 
Co-infection with HIV and tuberculosis introduces an extra dimension to the 
pathophysiology of wasting, exacerbating the wasting seen in tuberculosis or HIV infection 
alone.2,8 Nutritional alterations in tuberculosis, HIV infection, or tuberculosis and HIV combined 
include increased energy expenditure, nutrient malabsorption, micronutrient malnutrition, and 
increased production of inflammatory cytokines with lipolytic and proteolytic activity.5,9 
Although the association between malnutrition and co-infection with tuberculosis and HIV has 
been described, it is uncertain whether improved nutrition reduces the risk of developing active 
disease or improves the clinical outcome during treatment.10 Despite adequate chemotherapy, 
morbidity and mortality are still high among patients with tuberculosis, especially in those co-
infected with HIV. In popular public health terms, HIV and tuberculosis co-infection are “double 
trouble,” and a combination of HIV and tuberculosis with malnutrition may well represent “triple 
trouble.” The goal of this review is to present the current state of knowledge regarding the 
nutritional status of patients co-infected with tuberculosis and HIV, to describe changes in 
nutrition indicators during tuberculosis chemotherapy, and to examine the relationship between 
nutrition and clinical outcomes. 
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Micronutrient Malnutrition 
A number of micronutrient deficiencies have been described in individuals with 
tuberculosis11–21 and in those with HIV infection.22–28 Several cross-sectional studies suggest that 
patients with tuberculosis suffer from deficiencies of vitamin A,12,16,17 thiamin,18 vitamin B6,19 
folate,11,20 and vitamin E.21 Deficiencies of vitamin A, vitamin E, thiamin, riboflavin, vitamin B6, 
and vitamin C are more prevalent among HIV-infected adults than in those without HIV 
infection.24–28 Among these micronutrients, perhaps vitamins A and D have received the most 
attention in patients with tuberculosis. Much of the interest in vitamins A and D relates to 
historic use of cod-liver oil as treatment for tuberculosis prior to the era of antibiotics.10 
Vitamin A 
Vitamin A deficiency, manifested in night blindness, Bitot spots, low hepatic vitamin A 
stores, and low plasma vitamin A concentrations, has been described among children and adults 
with tuberculosis.17,29–35 Vitamin A is essential to normal function of T and B lymphocytes, 
macrophage activity, and generation of antibody responses.36 In experimental studies, vitamin 
A–deficient animals showed increased susceptibility to infection with Mycobacterium compared 
with pair-fed or ad libitum–fed control animals.37–39 Supplemental vitamin A appears to increase 
survival among chicks infected with M tuberculosis40 and enhances both T lymphocyte and 
antibody responses to M tuberculosis.41 
Vitamin A status has been examined in different populations infected with HIV; these 
studies generally show that lower plasma or serum vitamin A concentrations are found in 
developing countries compared with in developed countries.42 There have been few studies that 
have examined vitamin A status among individuals co-infected with tuberculosis and HIV. In a 
cross-sectional study in Rwanda, 29% of adults with both HIV and tuberculosis had serum 
vitamin A concentrations indicative of deficiency (<1.05 µmol/L).43 These data suggested that 
women had lower mean serum vitamin A concentrations than men (1.22 ± 0.45 vs. 1.47 ± 0.68 
µmol/L, P = 0.07). In a longitudinal study of 519 adults co-infected with tuberculosis and HIV in 
Kampala, Uganda, 36% had serum vitamin A concentrations consistent with deficiency (<1.05 
µmol/L) at the time of presentation (Langi P, Semba RD, Whalen C, unpublished data, 2002). 
During follow-up time (median) of 17 months, 30% of subjects with serum vitamin A <1.05 
µmol/L, and 17% of subjects with serum vitamin A <1.05 µmol/L died (P <0.01). In multivariate 
analyses that adjusted for CD4+ lymphocyte count, age, sex, body mass index, and diarrheal 
21 
morbidity, vitamin A deficiency was associated with increased risk of death (relative risk = 1.78, 
95% confidence interval [CI] 1.2–2.6). 
Vitamin D 
Vitamin D plays a role in the function of macrophages, key factors in host resistance to 
tuberculosis.44 Abnormalities in vitamin D status have been reported in tuberculosis, but there 
are many dietary, genetic, and environmental factors, such as exposure to sunlight, that may 
influence vitamin D status. Recently, genetic variations in the vitamin D receptor were identified 
as a major determinant of the risk for tuberculosis in Africans.45 By contrast, a case-control study 
among Indians living in London showed only a marginal influence of these receptor genotypes, 
and vitamin D deficiency itself was shown to be a risk factor for tuberculosis.46 Adults with 
untreated tuberculosis Indonesia were shown to have significantly lower 25-hydroxyvitamin D 
compared with controls.47 In a study of 15 adults with untreated pulmonary tuberculosis and 15 
healthy controls, 25-hydroxyvitamin D concentrations were not significantly different, but 1,25-
dihydroxyvitamin D concentrations were significantly lower among those with tuberculosis than 
in controls.48 Studies have yielded inconsistent findings regarding serum or plasma calcium 
concentrations during tuberculosis.49–52 In HIV-infected adults, low serum levels of 1,25-
dihydroxyvitamin D3, the biologically active form of vitamin D, have been described in the 
presence of normal levels of 25-hydroxyvitamin D.53 Vitamin D status has not yet been 
examined among individuals co-infected with tuberculosis and HIV. 
Vitamin E 
Vitamin E may play a potential role in tuberculosis and HIV infection through its 
antioxidant properties. Increased oxidative stress may predispose individuals to failure of T 
lymphocyte–mediated immunity.54 In the era prior to highly active antiretroviral therapy, low 
plasma or serum vitamin E concentrations were reported among 4% of heterosexual adults and in 
10 to 20% of homosexual men and intravenous drug users.23,24,55,56 In a study of HIV-infected 
adults in Brazil, approximately 41% of patients had vitamin E levels <18 µmol/L.54 
Supplementation with vitamin E (800 mg/day) plus vitamin C (1 gm/day) reduced indicators of 
oxidative stress in HIV-infected adults in Toronto.57 Vitamin E status has not yet been 
characterized among individuals co-infected with tuberculosis and HIV. 
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B-Complex Vitamins 
There is limited data regarding the status of B-complex vitamins in individuals with 
tuberculosis. In a study in Nigeria, serum vitamin B12 concentrations were not significantly 
different between adults with tuberculosis and asymptomatic controls.4 Normal serum vitamin 
B12 concentrations were described in a study in Finland among adults with tuberculosis,11 and 
increased concentrations of vitamin B12 were described in pulmonary tuberculosis patients in 
South Africa.58 Low plasma folate concentrations are common in adults infected with 
tuberculosis.4,11–13 Low serum folate concentrations thought to represent incipient folate 
depletion were found in 45% of untreated British tuberculosis patients,20 whereas extremely low 
mean values (<4.5 nmol/L) were detected in Nigerian patients with tuberculosis.4 Cameron and 
Horne suggested that that excessive utilization of folate by the active inflammatory process 
contributes to folate deficiency.13 By contrast, among Nigerian adults suffering form pulmonary 
tuberculosis, the extent of the inflammatory process did not appear to influence folate status to 
any significant degree, nor was there any relationship found between red cell or serum folate and 
severity of anaemia.4,58 
Iron 
Anemia is highly prevalent among adults with pulmonary tuberculosis and also among 
adults with HIV infection.15,58–61 Although anemia of chronic disease accounts for a large part of 
the anemia found in tuberculosis, iron deficiency may also be a contributing factor.61 In a study 
conducted in Ghana, 50 adults with pulmonary tuberculosis had significantly lower hemoglobin 
than healthy matched controls.62 In Uganda, mean hemoglobin concentrations were lower among 
HIV-infected adults with tuberculosis than in HIV-uninfected adults with tuberculosis.63 Low 
plasma transferrin concentrations have been described among HIV-infected adults with 
tuberculosis.64 Further studies are needed to characterize the relative contribution of iron 
deficiency to the anemia found in co-infection with tuberculosis and HIV. 
Other Nutrients 
In countries were maize is the predominant staple food, Sammon speculated that the 
pattern of disease is largely determined by a change in immune profile caused by metabolites of 
dietary linoleic acid.65 High intake of linoleic acid in a diet deficient in polyunsaturated fatty 
acids and riboflavin may result in high tissue production of T-helper-1-like lymphocytes, which 
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are primarily involved in mediation of cellular immunity. Such dietary immune modulation may 
affect resistance to tuberculosis in certain geographic areas.65 In Indonesia, patients with 
tuberculosis had significantly lower plasma zinc concentrations.15 A case-control study from 
Miami showed that 12 people with tuberculosis were more likely to have low plasma selenium 
concentrations than 32 healthy controls.66 
Little is known about vitamin C status in tuberculosis. In a large longitudinal study from 
a low-income area of Philadelphia, low plasma concentrations of vitamins A and C were 
associated with an increased risk of developing tuberculosis.67 Indian immigrants in London 
have been studied to reveal the impact of a vegetarian diet upon the risk of tuberculosis. Two 
separate case-control studies confirmed that lacto-vegetarians are at greater risk than meat or fish 
eaters. Low vitamin B12, iron, and vitamin D intake may explain this association.10,14,69–71 
Protein-Energy Status 
Protein-energy malnutrition is common among adults with tuberculosis and HIV 
infection. Several studies have shown significant differences in serum albumin concentrations 
between adults with untreated tuberculosis and healthy controls (Table 1). Mean (± SD) albumin 
concentrations range from 3.0 ± 0.7 g/dL among people with tuberculosis in Kenya to a mean of 
3.9 ± 0.6 g/dL among people with tuberculosis in England.48–50,52,58,72,73 Table 2 shows the 
comparisons made between serum albumin concentrations among adults co-infected with 
tuberculosis and HIV and among those with tuberculosis alone. The differences were significant 
in all cases; mean serum albumin concentrations among adults co-infected with tuberculosis and 
HIV ranged from 2.0 g/dL in Burundi and Haiti to 2.9 g/dL in Uganda.7,63,74 A descriptive study 
showed hypoalbuminemia (<3.0 g/dL) in 72% of 265 patients with pulmonary tuberculosis in 
South Africa.58 These various studies demonstrate that hypoalbuminemia is common in people 
co-infected with tuberculosis and HIV. Other factors can influence serum albumin 
concentrations, including the acute-phase response.75 
Other studies have used prealbumin and transferrin in addition to albumin as serum 
indicators of protein status. In Burundi, the mean (± SD) serum prealbumin concentrations 
among 22 HIV-infected adults with tuberculosis were 0.09 ± 0.06 g/L versus 0.12 ± 0.05 g/L 
among adults with tuberculosis alone. Mean serum transferrin concentrations were 1.3 ± 0.5 g/L 
among HIV-infected adults with tuberculosis compared with 2.0 ± 0.7 among those with 
tuberculosis alone (P = 0.006).7 Lower serum transferrin concentrations are consistent with 
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decreased hepatic synthesis of proteins, and these effects may be linked to the acute protein 
malnutrition that occurs during the acute-phase response.54 Among Indian patients with 
tuberculosis, whole-body protein metabolism has been studied using 13C-labelled leucine.76 A 
greater proportion of ingested protein was oxidized in patients with tuberculosis during the fed 
state compared with the fasting state; this indicates a resistance to the anabolic effects of food. 
This “anabolic block” may represent one of the mechanisms for wasting. Energy metabolism 
was not measurably disturbed; patients with tuberculosis showed the same down-regulation of 
resting energy expenditure with a loss of lean body mass as undernourished healthy controls.76 In 
two studies that used total protein as an indicator of protein nutrition, no significant differences 
were found between HIV-infected adults with tuberculosis, healthy controls, and HIV-infected 
adults without tuberculosis.48,77 
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Table 1. Serum Albumin Concentrations in Adults with Untreated Pulmonary Tuberculosis with 
Unknown HIV Status Compared with Healthy Controls 
__________________________________________________________________________________ 
Location      Mean Serum Albumin (g/dL ± SD)  P  Reference 
  TB cases [n]  Healthy Controls [n] 
__________________________________________________________________________________ 
England 3.9 ± 0.6 [47]  4.5 ± 0.3 [47]  <0.001  48 
Kenya  3.0 ± 0.7 [15]  4.1 ± 0.3 [15]  <0.001  49 
Belgium 3.5 ± 0.8 [22]  4.1 ± 0.3 [27]  <0.001  50 
China   3.6 ± 0.7 [25]  4.3 ± 0.4 [25]  <0.001  52 
Malawi  3.7 ± 0.7 [104]  4.0 ± 0.3 [104]  <0.001  72 
England 3.7 ± 0.7 [30]  4.6 ± 0.2 [30]  <0.001  73 
__________________________________________________________________________________ 
 
 
 
Table 2. Serum Albumin Concentrations in Adults with Pulmonary Tuberculosis  
with and without HIV Infection 
__________________________________________________________________________________ 
Location       Mean Serum Albumin (g/dL ± SD)  P  Reference 
HIV-positive [n] HIV-negative [n] 
__________________________________________________________________________________ 
Burundi  2.0 ± 0.6 [22]  2.9 ± 0.4 [11]  <0.001  7 
Uganda 
 men  2.9 ± 0.4 [163]  3.2 ± 0.4 [199]  <0.001  63 
 women  2.9 ± 0.5 [98]  3.2 ± 0.5 [79]  <0.001 
Haiti* 
 men  2.1 ± 0.15 [27]  2.8 ± 0.1 [56]  <0.01  74 
 women  2.0 ± 0.16 [21]  2.6 ± 0.1 [46]  <0.01  
__________________________________________________________________________________ 
* SEM 
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Anthropometry And Body Composition 
Undernutrition is often defined as a having a low body mass index (BMI kg/m2) of 
<18.5.78 Several studies have shown that BMI is lower in adults with pulmonary tuberculosis 
than in healthy controls (Table 3),72,73,76,79 and that BMI is lower in HIV-infected adults with 
tuberculosis than in HIV-negative adults with tuberculosis (Table 4).5,7,63,80  In Uganda, no 
difference was found in BMI between HIV-positive and HIV-negative adults with pulmonary 
tuberculosis.63 Among HIV-positive subjects with tuberculosis, BMI was significantly lower 
among those with CD4+ lymphocyte count ≤200 cells/µL compared with those who had >200 
cells/µL.63 In Brazil, no significant differences were found in BMI between HIV-positive adults 
with and without pulmonary tuberculosis,77 but the number of subjects in both groups was small. 
Arm muscle circumference (AMC, calculated as arm circumference – [3.14 × triceps 
skinfold thickness]),81 has been used in a few studies evaluating nutritional status in adults with 
pulmonary tuberculosis. Mean (± standard deviation) AMC values have ranged from 14.8 ± 2.7 
cm among 32 female Nigerians to 20.4 ± 2.5 cm among male Malawians.72,82 Two studies in 
Haiti and England showed significant differences between AMC in adults with tuberculosis and 
healthy controls.73,74 Mid–upper arm circumference (MUAC) was significantly lower among 
adults with pulmonary tuberculosis than in healthy controls, and was significantly lower among 
HIV-positive adults with tuberculosis than in HIV-negative adults with tuberculosis.5,74,79,82 A 
mean MUAC of 19.5 ± 2.6 cm was reported among 239 HIV-infected adults with tuberculosis in 
Ethiopia.79 Mean triceps skinfold thickness is also lower in adults with pulmonary tuberculosis 
than in healthy controls, and in HIV-positive adults with tuberculosis than in HIV-negative 
adults with tuberculosis.5,73,74 
Bioelectric impedance analysis or water dilution methods have been used to examine the 
body composition in pulmonary tuberculosis patients (Table 5).5,7,63,64,77 Overall, there do not 
appear to be large differences in body composition between HIV-infected adults with 
tuberculosis and HIV-negative adults with tuberculosis. No significant differences have been 
found in absolute measures of body cell mass, total body water, or extracellular water between 
HIV-positive and HIV-negative adults with tuberculosis.5,7,63 Among adults with pulmonary 
tuberculosis in Uganda, the ratio of intracellular water to extracellular water (ICW:ECW) and 
phase angle was lower among men who were HIV-positive than in men who were HIV-
negative.63 Among the HIV-positive adults, the ICW:ECW ratio, body cell mass, fat mass, and 
phase angle were significantly lower among those with CD4+ lymphocyte count ≤200 cells/µL 
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than in those who had >200 cells/µL.63 A study conducted in Brazil among homeless HIV-
infected adults showed significantly lower body cell mass, ICW, and ECW among HIV-infected 
adults with tuberculosis than in HIV-infected adults without tuberculosis.77 
 
Table 3. Body Mass Index (BMI) in Adults with Untreated Active Pulmonary Tuberculosis 
with Unknown HIV Status Compared with Healthy Controls 
__________________________________________________________________________________ 
Location      Mean BMI (kg/m2 ± SD)  P  Reference 
  TB cases [n]  Healthy controls [n] 
__________________________________________________________________________________ 
Malawi 
 men 17.3 ± 2.2 [73]  21.7 ± 2.6 [73]  <0.01  72 
 women 18.3 ± 2.9 [49]  23.5 ± 3.0 [49]  <0.01 
England 19.3 ± 3.7 [30]  22.2 ± 2.6 [30]  <0.01  73 
India  17.7 ± 2.5 [9]  22.6 ± 1.5 [7]  <0.01  76 
Ethiopia 16.7 ± 2.3 [239] 21.8 ± 2.4 [239] <0.01  79 
__________________________________________________________________________________ 
 
 
Table 4. Body Mass Index (BMI) in Adults with Untreated Active Pulmonary Tuberculosis  
with and without HIV Infection 
__________________________________________________________________________________ 
Location            Mean BMI (kg/m2 ± SD)   P  Reference 
HIV-positive [n] HIV-negative [n] 
__________________________________________________________________________________ 
Burundi  16.7 ± 2.2 [56]  19.6 ± 2.8 [11]  <0.01  5 
Burundi  15.1 ± 2.8 [22]  18.6 ± 2.4 [11]  <0.01  7 
Uganda 
 men  18.1 ± 1.8 [163] 18.1 ± 2.2 [199] NS  63 
 women  19.8 ± 3.4 [98]  19.3 ± 2.7 [79]  NS 
Tanzania 
 men  16.4 ± 1.7 [32]  17.6 ± 1.8 [67]  <0.01  80 
 women  18.2 ± 2.8 [21]  17.6 ± 1.9 [28]  NS 
__________________________________________________________________________________ 
NS = not significant. 
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Changes In Nutritional Status During Tuberculosis Chemotherapy 
Several studies have shown that nutritional indicators, such as anthropometric 
measurements, improve during tuberculosis chemotherapy.72,73,83–85 A study conducted in 
Malawi showed that among 1181 adults with tuberculosis, weight significantly increased after 4 
weeks of treatment.85 HIV-negative adults with tuberculosis gained significantly more weight 
than HIV-positive adults with tuberculosis during the same period.84,85 By contrast, a report from 
Tanzania suggested that HIV-positive patients gained more weight than HIV-negative patients 
during tuberculosis chemotherapy.80 Although nutritional status seems to improve during 
tuberculosis chemotherapy, weight loss was observed in most of the 200 patients after 
completing treatment, and the length of hospital stay appeared to be the most important 
determinant of weight gain.80 Serum albumin concentrations and MUAC may remain subnormal 
after completion of tuberculosis chemotherapy, suggesting that body protein reserves may not 
fully recover.10,62,72,73 Hemoglobin concentrations also appear to improve during the first months 
of tuberculosis chemotherapy.62 
 
Nutritional Status And Clinical Outcomes 
Nutritional status appears to be an important determinant of clinical outcome during 
tuberculosis. In an influential study conducted in India, 163 patients with tuberculosis were 
treated either in a sanatorium with a well-balanced diet or at home on a markedly poorer diet.83 
The overall treatment response was similar in both groups; however, those receiving better 
nutrition tended to show more rapid clearance of bacteria and radiographic changes in addition to 
greater weight gain.83 (Serum albumin and hemoglobin concentrations are strong predictors of 
survival in adults with pulmonary tuberculosis.86) In a study in Malawi, among 1181 patients 
with tuberculosis, of whom 80% were HIV-positive, 8% of patients died within the first 4 weeks 
of treatment. Risk factors for early mortality included age >35 years, HIV seropositivity, and a 
high degree of malnutrition.87 Among adults with moderate to severe malnutrition, 10.9% died in 
the first 4 weeks of treatment as opposed to 6.5% death rate in adults who were normal or had 
mild malnutrition (odds ratio 1.8, 95% CI, 1.1–2.7). Among HIV-infected patients with 
tuberculosis, a BMI <17.0 appears to be a strong predictor of early mortality.87 
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Table 5. Body Composition in Adults with Untreated Active Pulmonary Tuberculosis  
with and without HIV Infection 
________________________________________________________________________________ 
Location Indicator         Mean ± SD   P Reference 
HIV-positive [n] HIV-negative [n] 
__________________________________________________________________________________ 
Burundi BCM (kg) 36.3 ± 4.0 [56]  40.4 ± 4.3 [11]  NS 5 
Burundi BCM/H2 8.2 ± 1.7 [22]  9.6 ± 1.4 [11]  NS 7 
Uganda  BCM (kg) 
 men   21.5 ± 3.4 [163] 21.9 ± 3.8 [199] NS 63 
 women   16.2 ± 2.8 [98]  16.5 ± 2.2 [79]  NS 
Burundi TBW (L) 27.0 ± 5.6 [22]  30.0 ± 6.1 [11]  NS 7 
Uganda  TBW (L) 
 men   33.1 ± 4.0 [163] 33.0 ± 4.2 [199] NS 63 
 women   27.3 ± 3.7 [98]  27.4 ± 3.0 [79]  NS 
Burundi ECW (L) 13.6 ± 2.2 [22]  14.6 ± 1.6 [11]  NS 7 
Uganda  ECW (L) 
 men   13.4 ± 1.9 [163] 12.8 ± 1.9 [199] NS 63 
 women   12.5 ± 1.6 [98]  12.3 ± 1.4 [79] 
Burundi ICW/H2 1.3 ± 0.4 [22]  1.5 ± 0.4 [11]  NS 7 
Uganda  ICW (L) 
 men   19.6 ± 3.0 [163] 20.0 ± 3.4 [199] NS 63 
 women   14.8 ± 2.6 [98]  15.0 ± 2.1 [79]  NS 
Burundi ICW:ECW 1.1 ± 0.2 [22]  1.1 ± 0.3 [11]  NS 7 
Uganda  ICW:ECW 
 men   1.48 ± 0.26 [163] 1.59 ± 0.48 [199] <0.01 63 
 women   1.19 ± 0.16 [98] 1.23 ± 0.15 [79] 
Burundi FM (kg) 10.4 ± 4.0 [56]  13.8 ± 4.3 [11]  <0.01 5 
Uganda  FM (kg) 
 men   4.23 ± 2.72 [163] 4.40 ± 3.32 [199] NS 63 
 women   13.0 ± 7.2 [98]  12.2 ± 5.4 [79]  NS 
Uganda  FM (% of weight) 
 men   7.7 ± 4.4 [163]  7.8 ± 5.4 [199]  NS 63 
 women   24.8 ± 9.5 [98]  23.9 ± 7.7 [79]  NS 
Burundi FM/H2  2.3 ± 1.7 [22]  3.8 ± 4.4 [11]  <0.01 7 
Uganda  phase angle α (°) 
 men   5.42 ± 1.05 [163] 5.76 ± 1.3 [199] <0.01 63 
 women   5.35 ± 1.27 [98] 5.43 ± 0.93 [79] NS 
_________________________________________________________________________________ 
BCM = body cell mass, H = height, TBW = total body water, ECW = extracellular water, ICW = 
intracellular water, FM = fat mass. 
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The Role of Nutritional Supplements 
A number of studies have examined the role of nutritional supplements in tuberculosis. In 
a recent placebo-controlled trial from Indonesia,88 daily supplements of vitamin A and zinc given 
to adults with pulmonary tuberculosis led to significant improvements in the lesion area observed 
on chest radiographs after 2 months of tuberculosis chemotherapy; this was not the case at the 
six-month follow-up. The supplements resulted in earlier clearance of tubercle bacilli from 
sputum. However, no effects of the supplements were observed on the number of cavities, the 
surface area of cavities, hemoglobin concentrations, or different anthropometric indicators of 
nutritional status. In another trial among 110 new cases of active tuberculosis, subjects received 
tuberculosis chemotherapy alone or in addition to injectable thiamin, vitamin B6, or vitamin C, or 
an oral multivitamin supplement. All groups receiving any vitamin supplementation had 
significantly better lymphocyte proliferation responses (in response to phytohemagglutinin or 
purified protein derivative) than the arm of the study receiving no vitamin supplementation.89 
There were no differences in responses at baseline between the treatment arms. Another trial 
showed that vitamins C and E were effective in improving immune responses to tuberculosis 
when given as adjuncts to multidrug tuberculosis therapy.90 
Data from asymptomatic HIV-positive individuals in observational studies indicate that 
higher intakes of individual micronutrients and multivitamins are related to better outcomes in 
terms of CD4+ lymphocyte counts, clinical progression to AIDS, and overall mortality.91 Serum 
concentrations of vitamins A, B12, and E were also associated with HIV disease progression.56,92–
94 Recently, plasma selenium concentrations were found to be associated with increased risk of 
mycobacterial infection among HIV-infected intravenous drug users in Miami.95 Nearly all of the 
above studies adjusted for potential confounding by other variables including use of prophylactic 
medications and antiretroviral therapy, baseline CD4+ lymphocyte counts, and albumin 
concentrations. It is difficult to exclude the possibility of residual confounding by other causal 
variables that were not measured. In addition, biochemical markers of nutritional status have 
some limitations. Low plasma vitamin A and zinc concentrations can be depressed in the 
presence of an acute-phase response despite adequate body stores. Dietary intake studies are also 
limited because dietary patterns may change as a result of disease; reverse causality may 
therefore explain the associations between dietary intake and stage of disease. Randomized 
controlled trials will still provide the best causal evidence to examine the issues related to 
nutritional status and outcomes among patients with tuberculosis and HIV infection. 
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Conclusion 
Although malnutrition appears to play an important role in the clinical course of co-
infection with tuberculosis and HIV, further studies are needed to characterize the potential role 
of micronutrients––vitamin E, vitamin C, zinc, and B-complex vitamins––in the pathogenesis of 
tuberculosis and HIV co-infections. Malnutrition may influence the outcome of HIV infection 
and tuberculosis, accelerating the progression of immunosuppression, but it is unclear whether 
nutritional intervention will slow progression of disease. For example, it is not known whether 
the addition of a low cost vitamin and mineral supplement to tuberculosis chemotherapy would 
help improve morbidity and mortality. The repletion of tissue mass in patients recovering from 
tuberculosis may not be attained without relatively high levels of nutritional intake.96 Controlled 
clinical trials currently in progress in developing countries should help provide insight into the 
role of micronutrient supplementation for adults co-infected with pulmonary tuberculosis and 
HIV. 
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Abstract 
There is limited insight into the relationship between malnutrition and the clinical features of 
tuberculosis.  The relationship between malnutrition and the severity of lung disease was 
examined in human immunodeficiency virus (HIV)-positive and negative adults with pulmonary 
tuberculosis (PTB) in Zomba Central Hospital, Zomba, Malawi. Chest radiographs and 
anthropometric measurements were obtained and bioelectrical impedance analysis (BIA) was 
conducted in sputum-positive patients with PTB.  Lung disease in chest radiographs was graded 
as normal, minimal, moderately advanced, and far advanced according to a conventional 
classification system.  Among 319 adults with PTB with or without HIV co-infection, body mass 
index (BMI), fat mass, and phase angle were independently associated with increasing severity 
of lung disease.   Multiple logistic regression analyses showed that BMI, fat mass, and phase 
angle were associated with increasing severity of lung disease among 236 HIV-positive adults, 
when adjusted for sex, age, and plasma HIV load. The severity of lung disease in adults with 
PTB is associated with the extent of malnutrition, as reflected by BMI and body composition 
studies using BIA. 
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Introduction 
According to the World Health Organization (WHO), about one third of the world's 
population is infected with Mycobacterium tuberculosis, and the majority live in less developed 
countries where human immunodeficiency virus (HIV) infection is spreading rapidly.  In sub-
Saharan Africa, the Indian subcontinent, and southeast Asia, half or more of adults have latent 
tuberculosis infection.  The WHO estimated that the number of new cases of tuberculosis, and 
the proportion with coexisting HIV infection will continue to increase.1 The association between 
tuberculosis and malnutrition has long been recognized, as malnutrition predisposes to the 
development of clinical disease, and tuberculosis often exacerbates malnutrition.2,3  Individuals 
with immunosuppression have a greater risk of developing clinical tuberculosis, which explains 
the increased prevalence of tuberculosis in association with HIV infection.  In some countries in 
sub-Saharan Africa, including Malawi, the HIV seroprevalence rate among tuberculosis patients 
is over 75%.4-7  Co-infection with HIV and tuberculosis may result in an exacerbation of wasting 
seen in tuberculosis or HIV infection alone.2,8  However, there is limited insight into the 
relationship between malnutrition and the clinical features of tuberculosis. 
Although nutritional status is known to be a risk factor for pulmonary tuberculosis (PTB), 
the relationship between nutritional status and the severity of the disease has not been well 
characterized.  We hypothesized that more advanced lung disease, as assessed by chest 
radiographs, was associated with more severe malnutrition.  To test this hypothesis, we 
conducted a cross-sectional study to examine the relationship between malnutrition and the 
extent of lung disease in adults with PTB with and without HIV infection.  In addition to body 
mass index (BMI), body cell mass, fat mass, and phase angle derived from bioelectrical 
impedance analysis (BIA) were used to assess the extent of malnutrition in this study.  BIA, a 
simple and non-invasive technique, has been recommended for nutritional studies in HIV-
infected individuals and has been shown to be sufficiently precise for body composition 
analysis.8,9,10   BIA was shown to be a good predictor and superior to BMI as an estimator of 
body fat 10 Body cell mass, the total mass of all the cellular elements in the body, represents the 
metabolically active component of the body.  It comprises those tissues that are most likely to be 
affected by physical activity, nutrition, or disease, and appears to be an independent predictor of 
mortality among HIV-infected adults in the era prior to highly active antiretroviral therapy.11-14 
Phase angle, the relationship between resistance and reactance obtained from BIA, is considered 
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to reflect water distribution between extra- and intracellular spaces and has been shown to be an 
independent predictor of mortality during HIV infection.13,15,16 
 
Methods 
The study population consisted of adults who presented with new sputum-positive PTB 
in Zomba Central Hospital between July 1999 and December 2000.  Subjects were offered HIV 
testing and were screened for HIV antibodies after written informed consent had been obtained.  
All subjects were given appropriate pre- and post-test HIV counselling.  At enrollment, basic 
demographic information and a medical history were collected and a standardized physical 
examination was conducted.  Subjects received standard short course chemotherapy for 
tuberculosis as per guidelines of the Malawi National Tuberculosis Programme.17  Adults with a 
previous history of treated PTB were excluded.  Three sputum samples from each subject were 
examined with Auramine-O dark-fluorescent staining method.  Sputum positive PTB was 
considered proven when at least one out of three sputum stains showed acid-fast bacilli.  HIV 
infection was diagnosed on the basis of a positive rapid test (Determine 1 / 2 Rapid test by 
Abbott, Johannesburg, South Africa) and confirmed by a positive enzyme-linked immunosorbent 
assay for HIV-1 antibodies (Wellcozyme; Wellcome Diagnostics, Dartford, Kent, UK).  Plasma 
HIV load was measured using quantitative HIV-1 RNA PCR (Roche Amplicor Monitor, version 
1.5, Branchburg, NJ, USA) with a sensitivity limit of 400 HIV RNA copies/mL.  The protocol 
was approved by the institutional review boards at the Johns Hopkins School of Medicine 
(Baltimore, Maryland, USA) and the College of Medicine, University of Malawi (Blantyre, 
Malawi), with final approval by the Office for Protection from Research Risk of the National 
Institutes of Health. 
Nutritional assessment 
Body weight was determined to the nearest 0.1 kg using an adult balance (Seca 700 
balance, Seca Corporation, Hanover, MD, USA), and standing height was determined to the 
nearest cm.  Single-frequency BIA was performed at 50 kHz and 800 µA (RJL Systems, Inc., 
Detroit, MI, USA) with standard tetrapolar lead placement.18  BIA measurements were 
performed in triplicate for each subject.  The reproducibility on repeated BIA measurements was 
>99%.   Impedance (Z) was calculated as (resistance 2 x reactance 2 ) 0.5 . Body cell mass was 
calculated as 0.76 [ Ht1.60 / Z(parallel)0.50 x 59.06 ] + 18.52 Wt  – 386.66/ 120 for males, and as 0.96 [ 
45 
Ht2.07 / Z(parallel)0.36 x 1.30 ] + 5.79 Wt  – 230.51/120 for females. Fat-free mass was calculated as 0.50 [ 
Ht1.48  / Z0.55 x 1.0 / 1.22 ] + 0.42 Wt  + 0.49 for males, and as 0.88 [ Ht1.97 / Z0.49 x 1.0 / 22.22 ] + 0.081 
Wt  + 0.07 for females.  Fat mass derived from BIA measures was calculated as body weight 
minus fat-free mass.  Phase angle was calculated as α = arctangent (reactance / resistance).19  
These equations were previously cross-validated in a sample of white, black and Hispanic 
patients with and without HIV infection8 and have been applied elsewhere in sub-Saharan 
Africa.20 
Radiographical findings 
A standard posterior-anterior chest radiograph was taken of each subject.  All radiographs 
were examined by an experienced clinical officer in the Malawi National Tuberculosis Control 
Programme. Lung disease was graded according to an international classification of tuberculosis 
21:  (1) minimal lung disease was defined as infiltrates of slight to moderate density; disease 
present in a small portion of both lungs; the total volume of infiltrate(s) being the volume of one 
lung present above the 2nd chondrosternal junction and the spine of the fourth junction or the 
body of the 5th thoracic vertebra and no cavitations present; (2) moderate advanced disease was 
defined as: disease present in one or both lungs; the total extend not more than: a) scattered 
lesions of slight to moderate density do not involve more than the total volume of one lung or the 
equivalent volume of both lungs, b) dense, confluent lesions do not involve more than one third 
of the volume of one lung, c) the total diameter of the cavities are not greater than 4 cm; and (3) 
far advanced lung disease was defined as: lesions more extensive than moderate advanced 
disease.  All chest radiographs were interpreted by a reader blinded to the HIV status and clinical 
status of the subjects.  To lessen inter- and intra-observer differences, the chest radiographs were 
also read by a tuberculosis specialist (C.C.W.), and in cases of discordance in readings, films 
were reviewed and final classifications were reached by consensus. 
Data and statistical analysis 
Data and statistical analysis were conducted using SPSS 9.0 (SPSS, Inc., Chicago, IL, 
USA).   Comparisons between groups were made using t-tests and exact tests.  Univariate 
analysis of variance was used to test for linear trends across categories of lung disease.  
Nutritional status was assessed in adults with PTB with and without HIV co-infection.  Subjects 
were then separated into two groups according to the extent of malnutrition.  BMI (wt/ht2)<19 
was considered consistent with malnutrition.22   The proportion of adults with phase angle 
<5.3º was examined, as this cut-off was previously shown to be predictive of mortality among 
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HIV-infected adults.23    Body cell mass and fat mass were divided into quartiles, with the lowest 
quartile considered the most consistent with wasting.  Logistic regression models were fitted 
with BMI <19.0, phase angle <5.3º and the lowest quartile of fat mass and body cell mass as the 
outcome variable.  Multiple logistic regression models were conducted to adjust for sex, age, 
HIV co-infection and plasma HIV load.  A test for trend across the categories of extent of lung 
disease was performed by assigning the subjects the mean value of their allocated category and 
then entering this as a continuous variable into the logistic regression model.   A significance 
level of P <0.05 was used in this study. 
 
Results 
Characteristics of patients with pulmonary tuberculosis 
The study population consisted of 236 HIV-positive and 83 HIV-negative adults with 
sputum -positive PTB.  The overall HIV prevalence among the male and female participants was 
67%, and 80%, respectively.  The mean age among all subjects was 33 years, ranging from 18 to 
58 years. Education levels were significantly lower among female participants (32.5% of female 
versus 8.7% of male never attended school, P <0.01).  Of female participants 17.2% had 
continued education after primary school, versus 31.5% of male participants (P <0.01).  There 
were no significant differences in education levels by HIV status.  HIV-positive men with PTB 
had lower mean hemoglobin than HIV-negative men (Table1). 
Table 1.  Characteristics of HIV-positive and HIV-negative adults presenting with  
pulmonary tuberculosis in Zomba, Malawi 
Characteristics* Men  Women  
 HIV-positive HIV-negative P HIV-positive HIV-negative P 
 (n = 100) (n = 49)  (n = 136) (n = 34)  
Age (years) 36 (8) 34 (12)  0.28 32 (9) 30 (11)  0.18
Able to read (%) 93 87.8 0.29 70.9 55.9 0.09
Primary education or higher (%) 30 34.7 0.56 17.5 20.5 0.67
Hemoglobin (g/L) 96 (26) 111 (31) 0.01 92 (23)  99 (27) 0.13
Anemic (%)** 91 67.3 0.01 86 85.3 0.91
Plasma HIV load (copies x 103/mL)*** 278 (134, 703)   228 (94, 630)   
median (25th, 75th percentiles)       
*Mean (SD) for continuous variables.  
**Hemoglobin <120 g/L for females and <130 g/L for males. 
***HIV load not measured in 3 male and 10 female subjects. 
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Nutritional status 
The majority of subjects were malnourished, as overall 61% of subjects had a BMI <19.  
There were no significant differences found in weight, mean BMI or the proportion of 
individuals with BMI <19 between HIV-positive and -negative individuals. There were no 
significant differences in resistance, impedance, fat-free mass or fat mass between individuals 
with or without HIV infection.  Reactance, body cell mass, and phase angle was significantly 
lower in HIV-positive male participants than in HIV-negative male participants.  The proportion 
of participants with phase angle <5.3º was significantly higher in HIV-positive than in HIV-
negative male participants. These differences were not observed between the HIV-positive and 
HIV-negative female participants (Table 2). 
Table 3 shows the linear trends across categories of lung disease associated with 
nutritional indicators in HIV-positive and -negative subjects.  These data show that among the 
HIV-positive individuals, more advanced lung disease was shown to be associated with lower 
BMI, body cell mass, fat mass, and phase angle.  Among the HIV-negative individuals, more 
advanced lung disease was associated with lower BMI and lower phase angle. 
 
 
Table 2.  Body composition among HIV-positive and HIV-negative adults with  
pulmonary tuberculosis 
Characteristics* Men Women 
 HIV-positive 
(n = 100) 
HIV-negative 
(n = 49) 
P HIV-positive 
(n = 136) 
HIV-negative 
(n = 34) 
P 
Weight (kg) 52.7 (7.7) 52.0 (7.8) 0.62 45.8 (8.3) 45.7 (7.3) 0.96 
Height (cm) 169.4 (6.1) 167.3 (6.0) 0.04 157.4 (5.7) 156.2 (5.9) 0.28 
Body mass index 18.3 (2.3) 18.6 (2.4) 0.56 18.4 (2.9) 18.7 (2.7) 0.59 
Body mass index <19 (%) 62.0 65.3 0.69 61.0 61.7 0.93 
Reactance (ohms) 48 (14) 54 (14) 0.02 54 (16) 55 (14) 0.72 
Resistance (ohms) 573 (105) 570 (81) 0.91 675 (114) 667 (95) 0.71 
Impedance 575 (105) 573 (81) 0.90 678 (114) 670 (95) 0.71 
Body cell mass (% of weight) 39.2 (3.1) 40.6 (3.8) 0.02 33.0 (3.4) 32.8 (2.8) 0.70 
Fat-free mass (% of weight) 93.1 (5.2) 92.7 (5.0) 0.64 80.5 (8.7) 79.6 (9.2) 0.58 
Fat mass (% of weight) 6.9 (5.2) 7.3 (5.0) 0.64 19.5 (8.7) 20.4 (9.2) 0.58 
Phase angle (degrees) 4.8 (1.2) 5.4 (1.4) 0.01 4.6 (1.3) 4.7 (1.2) 0.55 
Phase angle <5.3° (%)  61.0 42.9 0.04 64.7 72.1 0.40 
*Mean (SD) for continuous variables. 
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Table 3.  Relationship of body composition and extent of lung disease in  
HIV-positive and HIV-negative adults with pulmonary tuberculosis 
  HIV-positive adults HIV-negative adults 
Extent of lung 
disease* 
Body mass 
index 
Body cell 
mass 
Fat mass Phase 
angle 
Body mass 
index 
Body cell 
mass 
Fat mass Phase 
angle 
Normal  19.0 (3.3) 34.8 (4.5) 18.7 (10.2) 5.0 (1.2) 22.1 (2.3) 42.1 (2.0) 13.8 (3.0) 7.2 (0.7)
Minimal 18.7 (2.5) 35.5 (4.7) 13.4 (9.8) 4.8 (1.2) 19.6 (2.5) 37.1 (5.0) 16.6 (10.1) 5.6 (0.8)
Mod-adv. 18.2 (2.6) 35.9 (4.5) 13.0 (9.5) 4.6 (1.3) 18.8 (2.8) 37.3 (6.0) 13.4 (11.3) 5.2 (1.4)
Far adv. 17.6 (2.1) 34.4 (3.8) 13.6 (8.5) 4.2 (1.2) 17.3 (1.3) 36.8 (4.7) 9.6 (7.7) 4.4 (1.3)
P for trend 0.05 0.05 0.02 0.01 0.01 0.14 0.06 0.01 
*Normal (n = 36, n =6), minimal (n = 95, n = 18), moderate-advanced (n = 61, n = 25), far advanced (n = 44, n = 
34) for HIV-positive and HIV-negative adults, respectively.  
**Mean (SD) for all body composition measures show. 
  
Table 4 shows crude and adjusted odds ratios (O.R.) and 95% confidence intervals (C.I.) 
for associations between extent of lung disease and lower BMI, body cell mass, fat mass, and 
phase angle in adults with PTB, with and without HIV co-infection.  When compared with 
normal lung appearance, far advanced lung disease was associated with lower BMI, fat mass, 
and phase angle as shown by crude and adjusted O.R.  The same applied for minimal and 
moderate advanced lung disease, which were associated with lower fat mass and BMI, 
respectively.  There was no significant relationship between body cell mass and extent of lung 
disease in adults with PTB with or without HIV co-infection in logistic regression analyses.  In 
considering the most marked comparison, for HIV-positive individuals with far advanced lung 
disease, the odds ratio for an independent association with lower BMI was 6.88 (95% C.I. 2.37-
19.93), with lower fat mass 9.98 (95% C.I. 2.01-49.70), and with lower phase angle 3.98 (95% 
C.I. 1.37-11.55) when adjusted for sex, age, and plasma HIV load (Table 5). 
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Table 4.  Extent of lung disease and risk of low body mass index, body cell mass, fat mass,  
and phase angle in adults with pulmonary tuberculosis 
Extent of lung 
disease 
Body mass index <19 Body cell mass,       
lowest quartile 
Fat mass,               
lowest quartile 
Phase angle <5.3 
 Crude    
O.R. 
Adjusted 
O.R.* 
Crude    
O.R. 
Adjusted 
O.R.* 
Crude    
O.R. 
Adjusted 
O.R.* 
Crude    
O.R. 
Adjusted 
O.R.* 
 (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) 
Normal 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
N = 42         
         
Minimal 2.02 1.97 0.85 1.21 3.17 2.54 1.43 1.54 
N = 113 (0.97-4.16) (0.95-4.09) (0.38-1.93) (0.47-3.09) (1.04-9.66) (0.78-8.26) (0.70-2.93) (0.73-3.25) 
         
Mod-advanced 2.79 2.86 0.75 0.84 3.89 4.15 1.81 2.11 
N = 86 (1.31-5.97) (1.33-6.19) (0.32-1.77) (0.32-2.28) (1.26-11.06) (1.24-13.82) (0.86-3.81) (0.95-4.65) 
         
Far advanced 8.12 8.83 1.25 1.5 3.73 4.94 3.11 4.32 
N = 78 (3.43-19.23) (3.64-21.42) (0.54-2.90) (0.56-4.03) (1.19-11.69) (1.44-17.01) (1.40-6.88) (1.81-10.32)
         
P for trend 0.0001 0.0001 0.19 0.51 0.02 0.007 0.003 0.0004 
*Adjusted for age, sex, and HIV infection. 
 
Table 5.  Extent of lung disease and risk of low body mass index, body cell mass, fat mass, and 
phase angle in HIV-positive adults with pulmonary tuberculosis 
Extent of lung 
disease 
Body mass index <19 Body cell mass,       
lowest quartile 
Fat mass,               
lowest quartile 
Phase angle <5.3 
  Crude    
O.R. 
Adjusted 
O.R.* 
Crude    
O.R. 
Adjusted 
O.R.* 
Crude     
O.R. 
Adjusted 
O.R.* 
Crude    
O.R. 
Adjusted    
O.R.* 
  (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) 
Normal  1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
N = 35          
          
Minimal  1.76 1.77 0.69 1.24 3.06 4.11 1.38 2.08 
N = 95  (0.81-3.83) (0.76-4.15) (0.30-1.63) (0.45-3.40) (0.98-9.50) (0.98-17.26) (0.63-3.04) (0.86-5.06) 
          
Mod-advanced 2.12 2.33 0.62 0.73 3.09 6.22 1.5 2.15 
N = 61  (0.92-4.89) (0.94-5.80) (0.24-1.57) (0.25-2.11) (0.95-10.06) (1.36-28.37) (0.64-3.51) (0.83-5.61) 
          
Far advanced  4.86 6.88 1.57 1.47 2.67 9.98 2.43 3.98 
N = 44  (1.82-13.0) (2.37-19.93) (0.62-3.99) (0.50-4.27) (0.77-9.25) (2.01-49.70) (0.92-6.40) (1.37-11.55)
          
P for trend  0.0002 0.0003 0.09 0.3 0.05 0.02 0.08 0.02 
*Adjusted for age, sex, and plasma HIV load. 
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Discussion 
This study demonstrates that the extent of pulmonary disease, as assessed by chest 
radiographs, is associated with the severity of malnutrition.  Few studies in sub-Saharan Africa 
have examined the relationship between malnutrition and the severity of lung disease.  To our 
knowledge, the present study is the first to examine the relationship between body composition 
using BIA and the severity of lung disease among HIV-positive and -negative adults with PTB.  
One of the advantages of BIA over BMI alone is that BIA can differentiate the degree of body 
fat and body cell mass in individuals.   However, BMI was still a sensitive indicator of 
malnutrition in this study and may be considered as an adequate indicator in a resource-poor 
setting.  In a previous study from Nigeria, patients with PTB and more severe lung disease had 
lower weight, arm circumference, and hand grip strength than those with limited lung disease.24 
Another study from Malawi showed that nutritional status declined with the extent of lung 
disease and in the presence of cavitation.25   
The main alterations associated with advanced lung disease in both HIV-positive and -
negative adults with PTB were lower BMI, fat mass, and phase angle.  A mean BMI of 17 in 
HIV-negative adults among adults with far advanced pulmonary disease are consistent with 
extremely poor nutritional status.  Several studies have shown that BMI is lower among adults 
with PTB compared with healthy controls,25-28 and that BMI is lower in HIV-infected adults with 
tuberculosis compared with HIV-negative adults with tuberculosis.4,6,20,29 The data from the 
present study are consistent with other studies that have described body composition in adults 
with PTB.3,24,25  A study among Ethiopian PTB patients showed that malnutrition influences the 
clinical and radiographic features, and the risk for atypical presentation of PTB was high among 
severely malnourished HIV-infected patients.26 
Phase angle, the relationship between resistance and reactance, is considered a marker for cell 
membrane integrity and has been shown to be an independent predictor of mortality during HIV infection. 
15,23 It is still unclear why this derived indicator from BIA is such a strong predictor of survival 
during HIV infection.  In healthy adults, the phase angle at 50 kHz is usually in the range of 8-
15° 30 Among HIV-infected adults on triple anti-retroviral therapy,16 the phase angle was 6.2° 
compared with a mean phase angle of 4.2° in HIV-positive and 4.4° in HIV-negative adults with 
far advanced pulmonary disease described in the present study. 
A limitation of the present study is that the assessment of lung disease through chest 
radiographs, although done with a descriptive grading scheme, is subjective.  The cross-sectional 
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design of this study restricts our conclusions and does not provide information on whether poor 
nutritional status is a predictor of more severe PTB. In a recent study from Thyolo District in 
southern Malawi, moderate to severe malnutrition as assessed by BMI, was a risk factor for early 
death, although the reasons are unknown.7  Wasting is a fundamental sign of tuberculosis in both 
HIV-positive and HIV-negative patients, and the etiology of the wasting has not been elucidated.  
Further studies are needed to examine the role of oxidative stress and antioxidant micronutrients, 
the role of inflammatory cytokines, and the relationship of severe lung disease to mortality.  It is 
unclear whether nutritional interventions will slow progression of disease or reduce morbidity 
and mortality if added to tuberculosis chemotherapy.  Controlled clinical trials currently in 
progress in developing countries should help provide insight into the role of micronutrient 
supplementation for adults with PTB, with and without HIV co-infection.  
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Abstract 
Wasting and micronutrient malnutrition have not been well characterized in adults with 
pulmonary tuberculosis.  We hypothesized that micronutrient malnutrition is associated with 
wasting and higher plasma human immunodeficiency virus (HIV) load in adults with pulmonary 
tuberculosis. In a cross-sectional study involving 579 HIV-positive and 222 HIV-negative adults 
with pulmonary tuberculosis in Zomba, Malawi, anthropometry, plasma HIV load and plasma 
micronutrient concentrations (retinol, α-tocopherol, carotenoids, zinc, and selenium) were 
measured.  The risk of micronutrient deficiencies was examined at different severity levels of 
wasting. Body mass index (BMI), plasma retinol, carotenoid and selenium concentrations 
significantly decreased by increasing tertile of plasma HIV load.  There were no significant 
differences in plasma micronutrient concentrations between HIV-negative individuals and HIV-
positive individuals who were in the lowest tertile of plasma HIV load.  Plasma vitamin A 
concentrations <0.70 µmol/L occurred in 61%, and zinc and selenium deficiency occurred in 
85% and 87% respectively.  Wasting, defined as BMI<18.5 was present in 59% of study 
participants and was independently associated with a higher risk of low carotenoids, and vitamin 
A and selenium deficiency.  Severe wasting, defined as BMI<16.0 showed the strongest 
associations with deficiencies in vitamin A, selenium and plasma carotenoids. These data 
demonstrate that wasting and higher HIV load in pulmonary tuberculosis are associated with 
micronutrient malnutrition. 
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Introduction 
Approximately one-third of the world's population is infected with Mycobacterium 
tuberculosis, and the majority live in less developed countries where human immunodeficiency 
virus (HIV) infection is spreading rapidly.  The World Health Organization (WHO) estimates 
that the number of new cases of tuberculosis and the proportion with coexisting HIV infection 
will continue to increase.1  Immunosuppression increases the risk of developing clinical 
tuberculosis, which contributes to the increased prevalence of tuberculosis in association with 
HIV infection.  Malnutrition and wasting are associated with tuberculosis, and co-infection with 
HIV and tuberculosis may potentially exacerbate the wasting that occurs in tuberculosis or HIV 
infection alone.2–5  Micronutrient deficiencies have been described in individuals with 
tuberculosis6-17 and in those with HIV infection.17-23  Several cross-sectional studies suggest that 
patients with tuberculosis are at high risk of deficiencies of vitamin A7,10,11,12, thiamin13, vitamin 
B6 14, folate6,15, vitamin E16, and zinc10.  Poor selenium status has recently been shown to 
increase the risk of developing mycobacterial disease among HIV-infected injection drug users24, 
but selenium status among HIV-infected adults with pulmonary tuberculosis has not been well 
characterized.  Selenium plays an important role in the selenoenzyme glutathione peroxidase that 
protects cells against free radical damage and oxidative stress. 
The relationship between severity of HIV disease and micronutrient malnutrition needs 
further elucidation. Such information would help identify subgroups that might benefit the most 
from nutritional interventions.  Plasma HIV load was used as an indicator of severity of HIV 
disease, as HIV load tends to be higher in more active HIV disease.  We hypothesized that 
wasting in pulmonary tuberculosis is associated with micronutrient malnutrition and that HIV-
infected adults with pulmonary tuberculosis who have more active HIV disease, as reflected by 
higher HIV load, also have more severe micronutrient malnutrition.  To test these hypotheses, we 
conducted a cross-sectional study to examine the relationship between wasting, HIV load and 
micronutrient malnutrition in HIV-positive and HIV-negative adults with pulmonary tuberculosis 
in Zomba, Malawi. 
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Methods 
The study population consisted of adults who presented with new sputum-positive 
pulmonary tuberculosis in Zomba Central Hospital between July 1999 and April 2003.  Subjects 
were offered HIV testing and were screened for HIV antibodies after signing a written informed 
consent form.  All subjects were given appropriate pre- and post-test HIV counselling.  Subjects 
commenced treatment after enrollment and received standard short course chemotherapy for 
tuberculosis as per guidelines of the Malawi National Tuberculosis Program.25  Adults with a 
previous history of treated pulmonary tuberculosis were excluded.  Three sputum samples from 
each subject were examined with Auramine-O dark-fluorescent staining method.  Sputum 
positive pulmonary tuberculosis was considered proven when at least one out of three sputum 
stains showed acid-fast bacilli.  HIV infection was diagnosed on the basis of a positive rapid test 
(Determine 1/2 Rapid test by Abbott, Abbott Laboratories, Johannesburg, SA) and confirmed by 
a positive enzyme-linked immunosorbent assay for HIV-1 antibodies (Wellcozyme; Wellcome 
Diagnostics, Dartford, Kent, UK).  Plasma HIV load was measured using quantitative HIV-1 
RNA PCR (Roche Amplicor Monitor, version 1.5, Branchburg, NJ, USA) with a sensitivity limit 
of 400 HIV RNA copies mL. CD4+ lymphocyte counts were not conducted due to limited 
resources. None of the participants were taking antiretroviral treatment. 
The protocol was approved by the institutional review boards at the Johns Hopkins School 
of Medicine (Baltimore, Maryland, USA) and the College of Medicine, University of Malawi 
(Blantyre, Malawi), with final approval by the Office for Protection from Research Risk of the 
National Institutes of Health. 
 
Nutritional assessment 
Body weight was determined to the nearest 0.1 kg using an adult balance (Seca 700 
balance, Seca Corporation, Hanover, MD, USA), and standing height was determined to the 
nearest cm.  Body mass index (BMI) was calculated as body weight/height2. 
 
Plasma Micronutrient Concentrations  
 A venous blood sample was collected by venipuncture (Sarstedt Monovette, Newton, 
NC).  Blood samples were shielded from bright light and immediately aliquoted and stored in 
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cryotubes at -70° C. α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein, zeaxanthin, 
retinol, and α-tocopherol concentrations were measured in 100 uL of plasma by high 
performance liquid chromatography using a modified method from the Nutrition Laboratory, 
Inorganic Toxicology and Nutrition Branch Division of Laboratory Sciences, National Center of 
Environmental Health, Centers of Disease Control and Prevention (Rosemary Schleicher, 
personal communication).26  Total plasma carotenoids were defined as the sum of α-carotene, β-
carotene, β-cryptoxanthin, lycopene, lutein and zeaxanthin in µmol/L. Plasma trace element 
concentrations were measured using a Perkin Elmer model AAnalyst 600 atomic absorption 
spectrometer equipped with Zeeman background correction, a THGA graphite furnace, and an 
AS800 auto sampler (Perkin Elmer Corp., Norwalk, CT).  Quality control was assessed by 
repeated analysis of pooled human plasma controls run at the beginning and the end of each 
analysis. Standard curves were run periodically using standard reference material 986C (National 
Institute of Standards and Technology, Gaithersburg, MD). Throughout all analyses, the plasma 
samples were run in a masked fashion. 
 
Data and Statistical Analysis 
 Data and statistical analysis were conducted using SAS 8.01 (SAS Institute Cary, NC, 
USA) and SPSS 9.0 (SPSS, Inc., Chicago, IL, USA).  Comparisons between groups were made 
using t-tests and nonparametric Mann-Whitney U-tests.  Univariate analysis of variance was 
used to test for linear trends across categories of plasma HIV load and BMI.    
HIV load was categorized into tertiles.  HIV negative subjects were assigned a fourth 
category of HIV load (category 0) when groups were merged for analysis. Nutritional status was 
assessed in adults with pulmonary tuberculosis with and without HIV co-infection.  Subjects 
were separated into groups according to their extent of wasting.  Mild wasting was defined as 
BMI 17.0-18.49, moderate wasting as BMI 16.0-16.99, and severe wasting as BMI <16.0, 
conform the WHO strata for BMI grading of severity of malnutrition.27   
Plasma retinol <0.70 µmol/L was considered consistent with vitamin A deficiency.28  
Vitamin E deficiency was defined as plasma α-tocopherol <11.6 µmol/L.28  Zinc deficiency was 
defined as plasma zinc <11.5 µmol/L and selenium deficiency as plasma selenium <0.89 
µmol/L.28  Because there is no standard cut-off for deficiency of carotenoids, we divided total 
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plasma carotenoids into quartiles, with the lowest quartile considered to be the most consistent 
with deficiency.  
To examine the risk of micronutrient deficiencies at different severity level of wasting, 
logistic regression models were fitted with retinol <0.70, α-tocopherol <11.6, zinc <11.5, 
selenium <0.89, and the lowest quartile of total carotenoids as the outcome variable.  
Multivariate logistic regression models were conducted to adjust for sex, age and HIV load.  A 
significance level of P <0.01 was used in this study. 
 
 
Results 
The study population consisted of 579 HIV-positive and 222 HIV-negative adults with 
sputum-positive pulmonary tuberculosis.  Among the total study population, 66% (232/352) of 
male and 77% (347/449) of female participants were HIV-positive.  The mean age among all 
subjects was 33 years (range 18-59 years).  The majority of subjects were wasted, as 59% of 
subjects had a BMI <18.5, 32% of subjects had a BMI <17.0, and 17% of all subjects were 
severely wasted as defined by BMI<16.0.  Plasma retinol concentrations <0.70 µmol/L and 
<1.05 µmol/L occurred in 61% and 84% of all subjects, respectively.  Vitamin E, zinc, and 
selenium deficiency occurred in 13%, 85% and 87% respectively.   
Table 1 shows characteristics of study participants, such as sex, age, BMI, and plasma 
carotenoids, retinol, α-tocopherol, zinc and selenium by categories of plasma HIV load.  
BMI, plasma retinol, total carotenoids and selenium concentrations decreased by increasing 
plasma HIV load.  Age, the proportion of individuals with BMI <18.5, BMI <16.0 and selenium 
deficiency were increased with increasing plasma HIV load.  Plasma α-tocopherol, zinc or the 
proportion of individuals with vitamin A, vitamin E, or zinc deficiencies were not significantly 
different across the categories of plasma HIV load.  When exploring across the categories 
separately, there were no significant differences between HIV-negative individuals compared 
with HIV-positive individuals in the lowest tertile of viral load. 
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Table 1. Characteristics of adults presenting with pulmonary tuberculosis in Zomba, Malawi  
by plasma HIV load 
Characteristic1 HIV negative HIV positive* 
Plasma HIV Load (copies/mL) 
P-value** 
 0 < 133 200 133 200 - 406 000 > 406 000  
 n=222 n=185 n=186 n=186  
Sex (% Female) 45.9 63.2 58.1 55.9 0.07 
Age (years) 33 + 12 32 + 12 33 + 12 33 + 12 0.01 
 
Body mass index (BMI) (wt/ht2) 
 
18.6 + 2.9 
 
19.0 + 2.6 
 
18.3 + 3.0 
 
17.3 + 2.7 
 
0.0001 
Wasting:2   No, BMI > 18.5  42.3 51.4 41.9 30.1 0.005 
                   Mild, BMI 17.0-18.49 (%) 32.0 27.0 22.6 24.2 0.04 
                   Moderate, BMI 16.0-16.99 (%) 13.1 10.3 17.2 18.8 0.04 
                   Severe, BMI <16.0 (%) 12.6 11.4 18.3 26.9 0.001 
 
Retinol (µmol/L)  
 
0.636 (0.367, 1.104) 
 
0.603 (0.336, 1.085) 
 
0.585 (0.321, 1.066) 
 
0.522 (0.157, 1.738) 
 
0.001 
Vitamin A deficiency, retinol <0.70 µmol/L (%)3 58.6 57.3 64.0 66.7 0.05 
Total Carotenoids (µmol/L)4 0.846 (0.490, 1.459) 0.795 (0.476, 1.329) 0.700 (0.385, 1.279) 0.509 (0.279, 0.929) 0.0001 
α-Tocopherol (µmol/L) 15.18 (11.71, 19.65) 14.90 (11.60, 19.16) 15.66 (11.85, 20.71) 16.07 (11.53, 22.40) 0.02 
Vitamin E def., α-tocopherol <11.6 µmol/L (%)3 13.1 14.6 11.8 12.4 0.67 
Zinc  (µmol/L) 8.95 (7.01, 11.43) 8.83 (6.94, 11.25) 8.49 (6.44, 11.19) 9.15 (6.47, 12.94) 0.82 
Zinc deficiency, zinc <11.5 µmol/L (%)3 84.2 88.1 87.6 77.4 0.09 
Selenium  (µmol/L)  0.687 + 0.23 0.664 + 0.22 0.624 + 0.22 0.559 + 0.21 0.0001 
Selenium deficiency, selenium<0.89 µmol/L (%)3 79.7 84.9  90.3 92.5 0.001 
1 Mean ±SD for continues variables with normal distribution, geometric mean (lower, upper SD) when distribution was not normal 
2 Grading based on WHO Expert report, reference 27.  
3 Cut-offs based on reference 28.  
4α-carotene + β-carotene + β-cryptoxanthin + lycopene + lutein + zeaxanthin 
* HIV load could not be determined for 21 individuals. 
**ANOVA, linear trend across the 4 categories of plasma HIV load.  
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Table 2 shows adjusted odds ratios (O.R.) and 95% confidence intervals (C.I.) for 
independent associations between wasting and micronutrient deficiencies. Wasting defined as 
BMI<18.5 was associated with vitamin A deficiency, low plasma carotenoids and selenium 
deficiency. The odds ratio for an independent association with vitamin A deficiency was 2.86 
(95% C.I. 2.11-3.89) when adjusted for sex, age, and plasma HIV load. The adjusted odds ratio 
for an independent association with the lowest quartile of total carotenoids was 2.96 (95% C.I. 
1.99-4.44). The adjusted odds ratio for an independent association with selenium deficiency was 
1.59 (95% C.I. 1.04-2.43) (Data not shown). When separating severity levels of wasting; mild 
wasting did not show association with deficiencies, moderate wasting was associated with 
vitamin A deficiency and severe wasting was significantly associated with vitamin A deficiency, 
low plasma carotenoids and selenium deficiency. (Table 2) Wasting was not associated with 
vitamin E or zinc deficiency.  
 
Table 2. Risk of micronutrient deficiencies at different severity levels of wasting in adults with 
pulmonary tuberculosis with and without HIV co-infection. 
 Mild wasting  Moderate wasting  Severe wasting  
 BMI 17.0-18.49  BMI 16.0-16.99  BMI <16.0  
Deficiency O.R. (95% C.I.)* P-value O.R. (95% C.I.)* P-value O.R. (95% C.I.)* P-value 
 
Vitamin A deficiency 
 
0.81 (0.58-1.13) 
 
0.20 
 
1.59 (1.03-2.47) 
 
0.03 
 
3.51 (2.19-5.72) 
 
0.0001
 
Lowest quartile of  
Total Carotenoids  
0.92 (0.62-1.36) 0.67 2.46 (1.57-3.85) 0.0001 1.82 (1.18-2.83) 0.007 
Vitamin E deficiency 0.86 (0.54-1.37) 0.54 1.24 (0.70-2.18) 0.46 1.13 (0.64-1.97) 0.68 
 
Zinc deficiency 0.71 (0.45-1.15) 0.17 0.61 (0.37-1.00) 0.05 0.76 (0.46-1.24) 0.27 
 
Selenium deficiency 1.59 (1.04-2.43) 0.03 1.16 (0.62-2.17) 0.65 3.25 (1.38-7.62) 0.007 
* Adjusted for sex (male), age (per year) and HIV load (quartiles, where category 0 is HIV negative and category 3 
is the highest) 
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Figures 1, 2 and 3 show plasma retinol, total plasma carotenoids, and plasma selenium 
concentrations with 95% C.I by severity of wasting and categories of plasma HIV load. Plasma 
retinol concentrations significantly decreased with the increase of plasma HIV load among non-
wasted adults with pulmonary tuberculosis (P=0.004). Total carotenoid concentrations 
significantly decreased with the increase of plasma HIV load among non-wasted, mildly wasted, 
moderately wasted and severely wasted adults (P=0.0001, P=0.002, P=0.001 and P=0.001, 
respectively).  Selenium concentrations decreased significantly with the increase of plasma HIV 
load among non-wasted and severely wasted adults with pulmonary tuberculosis (P=0.0001 and 
P=0.03, respectively). Among the HIV negative adults and those in the 1st and 2nd tertile of HIV 
load, plasma retinol, total carotenoids and selenium concentrations significantly decrease with 
the increasing severity of wasting. Among those in the 3rd tertile of HIV load, only plasma 
retinol concentrations significantly decreased with the increasing severity of wasting. This trend 
did not reach significance for plasma carotenoid and selenium concentrations.  
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Figure 1.  Log-transformed mean plasma retinol concentrations with 95% C.I. are depicted by severity of wasting 
and plasma HIV load. Among the not-wasted adults with pulmonary tuberculosis log mean plasma retinol 
concentration significantly decrease with the increase of plasma HIV load (P=0.004). Among those with mild, 
moderate and severe wasting this linear trend did not reach significance. Among the HIV negative adults with 
pulmonary tuberculosis, log mean plasma retinol concentration significantly decrease with the increasing severity of 
wasting (P=0.0001). The same trend appears among those in the 1st, 2nd and 3rd tertile of HIV load; P=0.0001, 
P=0.0001 and P=0.01 respectively.    
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Figure 2. Log-transformed mean plasma total carotenoid concentrations with 95% C.I. are depicted by severity of 
wasting and plasma HIV load. Among not-wasted, mildly wasted, moderately wasted and severely wasted log mean 
plasma total carotenoid concentrations significantly decrease with the increase of plasma HIV load (P=0.0001, 
P=0.002, P=0.001 and P=0.001, respectively). Among the HIV negative adults, and those in the 1st and 2nd tertile of 
plasma HIV load, log mean plasma total carotenoid concentrations significantly decreased with the increasing 
severity of wasting (P=0.007, P=0.002 and P=0.0001, respectively). This trend did not reach significance among 
those in the 3rd tertile of plasma HIV load.   
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Figure 3. Mean plasma selenium concentrations with 95% C.I. are depicted by severity of wasting and plasma HIV 
load. Among not-wasted and severely wasted adults, mean plasma selenium concentrations significantly decrease 
with the increase of plasma HIV load (P=0.0001 and P=0.03, respectively). This trend did not reach significance 
among those with mild and moderate wasting. Among the HIV negative adults, and those in the 1st and 2nd tertile of 
plasma HIV load, mean plasma selenium concentrations significantly decreased with the increasing severity of 
wasting (P=0.02, P=0.008 and P=0.0001, respectively). This trend did not reach significance among those in the 3rd 
tertile of plasma HIV load.    
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Discussion 
The present study shows that micronutrient malnutrition and wasting are more severe in adults 
with pulmonary tuberculosis who have higher plasma HIV load.  The association between high 
plasma HIV load and micronutrient deficiencies was strongest for the major plasma carotenoids 
and selenium.  Overall in this study population, both HIV-positive and HIV-negative adults with 
pulmonary tuberculosis were extremely malnourished as indicated by BMI and plasma 
micronutrient concentrations.  About one-third of the adults in this study had a BMI <17.0, a cut-
off that is predictive of mortality in adults co-infected with tuberculosis and HIV.29 
To our knowledge, this is the first study to demonstrate that selenium status is extremely 
poor among HIV-infected adults with pulmonary tuberculosis, and that the extent of selenium 
deficiency is associated with higher plasma HIV load.  This observation may be of potential 
importance because selenium deficiency has been associated with increased mortality during 
HIV infection 30, and selenium supplementation for HIV-infected adults has been shown to 
reduce morbidity.31  In the present study, selenium deficiency occurred in 87% of the 
participants, which, to our knowledge, may be the highest prevalence of selenium deficiency 
reported in an HIV-infected group of patients.  It is unknown whether selenium supplementation 
will reduce morbidity and mortality among HIV-infected adults with pulmonary tuberculosis. 
Carotenoids are among the most important dietary antioxidants found in human plasma, 
and this study shows that poor carotenoid status was associated with higher HIV load and with 
wasting.  Plasma carotenoid concentrations are widely considered to be the most accurate 
indicator of dietary carotenoid intake.32  It is not known whether adults with pulmonary 
tuberculosis and higher HIV load have lower plasma carotenoid concentrations because of 
increased oxidative stress, or whether these individuals are sicker and unable to consume enough 
carotenoid-rich foods.  Further studies are needed in the future to address dietary intake of 
carotenoids in HIV-infected adults with pulmonary tuberculosis. 
Low BMI is a known risk factor for mortality5,29, and the present study showed that the 
risk of micronutrient deficiencies is highest in those with low BMI. 
HIV-infected adults with wasting and high viral load were at the highest risk of more 
severe micronutrient malnutrition, suggesting that this subgroup might potentially benefit the 
greatest from nutritional interventions.   
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The cross sectional design of this study restricts our conclusions and does not provide 
information on whether poor nutritional status is a predictor of more severe pulmonary 
tuberculosis.  It is unknown whether nutritional interventions will slow progression of disease or 
reduce wasting associated with morbidity and mortality if added to tuberculosis chemotherapy.  
Controlled clinical trials currently in progress in developing countries should help provide 
insight into the role of micronutrient supplementation for HIV-positive and HIV-negative adults 
with pulmonary tuberculosis. 
The present study shows that micronutrient malnutrition and wasting are more severe in 
adults with pulmonary tuberculosis who have higher HIV load.  The association between high 
plasma HIV load and nutrient deficiencies was strongest for the major plasma carotenoids and 
selenium. Further longitudinal investigations are needed to determine whether deficiencies in 
micronutrients are independent risk factors for increased morbidity and mortality.   
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Abstract 
Although anemia is common among adults with pulmonary tuberculosis and human 
immunodeficiency virus (HIV) infection in sub-Saharan Africa, the factors contributing to its 
pathogenesis have not been well characterized.  The purpose of this study was to characterize the 
antioxidant micronutrient status, IL-6 concentrations, and HIV load in relationship with anemia 
in adults with pulmonary tuberculosis.  Erythropoietin, interleukin-6 (IL-6), plasma HIV load 
and markers of micronutrient status (hemoglobin (Hb), plasma concentrations of retinol, α-
tocopherol, carotenoids, ferritin, zinc, and selenium) were measured in 500 adults who presented 
with pulmonary tuberculosis in Zomba Central Hospital, Malawi.  Among 370 HIV-positive and 
130 HIV-negative adults, the prevalence of anemia was 88% and 77%, respectively (P=0.002), 
and moderate to severe anemia (Hb <80 g/L) occurred in 30% and 15%, respectively (P=0.001).  
Geometric mean IL-6 concentration was 21.1 pg/mL, with no difference between HIV-positive 
and HIV-negative adults. The erythropoietin response to anemia was not different between adults 
with elevated IL-6 and those with lower IL-6 concentrations. In a multivariate logistic regression 
model, HIV load and lower plasma selenium concentrations were associated with moderate to 
severe anemia. In a final multivariate linear regression model, IL-6, plasma HIV load and plasma 
selenium concentrations were associated with hemoglobin concentrations. This study suggests 
that low selenium concentrations, high HIV load and high IL-6 concentrations are associated 
with anemia in adults with pulmonary tuberculosis in sub-Saharan Africa. 
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Introduction 
Anemia is commonly associated with fatigue, poor quality of life and increased mortality, 
and also with human immunodeficiency virus (HIV) infection.1,2  Anemia is highly prevalent 
among HIV-infected adults with pulmonary tuberculosis and can be relatively severe.1,3-7  The 
pathogenesis of anemia associated with pulmonary tuberculosis has not been well characterized, 
especially in sub-Saharan Africa where there are the greatest number of cases of HIV infection 
and pulmonary tuberculosis.8 
The etiology of anemia during tuberculosis and HIV infection is thought to be 
multifactorial.  Although the anemia of infection, a subset of the anemia of chronic disease,9 may 
account for a large part of the anemia found in pulmonary tuberculosis, iron deficiency,1,10,11 
poor antioxidant status,1 and vitamin A deficiency 2,12 may potentially contribute to the anemia.  
A blunted response of erythropoietin to anemia may occur in the anemia of infection 9 and has 
been described in HIV-infected adults13,14 and children15. Interleukin-6 (IL-6), a pro-
inflammatory cytokine, is a marker for the severity of infection16 and has been shown to 
modulate the anemia of chronic disease17. 
The purpose of this study was to characterize the antioxidant micronutrient status, IL-6 
concentrations, and HIV load in relationship with anemia in adults with pulmonary tuberculosis. 
We hypothesized that poor antioxidant micronutrient status is associated with anemia in HIV-
infected and uninfected adults with pulmonary tuberculosis and that the response of 
erythropoietin to anemia is blunted among those with high levels of inflammation, characterized 
by elevated plasma IL-6 concentrations.  To test these hypotheses, we measured erythropoietin, 
IL-6, plasma HIV load and markers of micronutrient status, such as hemoglobin and plasma 
concentrations of retinol, α-tocopherol, carotenoids, ferritin, zinc, and selenium. 
 
Methods 
Study setting and population  
The study population consisted of 500 adults who presented with new sputum-positive 
pulmonary tuberculosis in Zomba Central Hospital between July 1999 and September 2001.  
Subjects were offered HIV testing and were screened for HIV antibodies after signing a written 
informed consent form.  All subjects were given appropriate pre- and post-test HIV counseling.  
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Subjects received standard short course chemotherapy for tuberculosis as per guidelines of the 
Malawi National Tuberculosis Program.18  Adults with a previous history of treated pulmonary 
tuberculosis were excluded.  Three sputum samples from each subject were examined with 
Auramine-O dark-fluorescent staining method.  Sputum-positive pulmonary tuberculosis was 
considered proven when at least one out of three sputum stains showed acid-fast bacilli.  HIV 
infection was diagnosed on the basis of a positive rapid test (Determine 1/2 Rapid test by Abbott, 
Abbott Laboratories, Johannesburg, SA) and confirmed by a positive enzyme-linked 
immunosorbent assay for HIV-1 antibodies (Wellcozyme; Wellcome Diagnostics, Dartford, 
Kent, UK). 
Anthropometry and laboratory measurements  
Body weight was determined to the nearest 0.1 kg using an adult balance (Seca 700 
balance, Seca Corporation, Hanover, MD, USA), which was attuned systematically and standing 
height was determined to the nearest cm.  Body mass index (BMI, wt/ht2) <18.5 was considered 
consistent with wasting.19   
Blood samples were obtained by venipuncture (Sarstedt Monovette, Newton, NC). 
Hemoglobin concentrations were measured using a hemoglobinometer (HemoCue Inc, Mission 
Viejo, CA, USA).  Aliquots of plasma were made in trace element-free cryovials, and samples 
were stored in liquid nitrogen.  Plasma samples were kept in liquid nitrogen or at –70º C until the 
time of laboratory analyses.  Plasma HIV load was measured using quantitative HIV-1 RNA 
PCR (Roche Amplicor Monitor, version 1.5, Branchburg, NJ, USA) with a sensitivity limit of 
400 HIV RNA copies mL.  Plasma erythropoietin (ALPCO, Windham, NH), ferritin (Human 
Ferritin Enzyme Immunoassay Test Kit, ALPCO, Windham, NH), and IL-6 (Human IL-6, R & 
D Systems, Minneapolis, MN) concentrations were measured by ELISA.   
Concentrations of α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein, zeaxanthin, 
retinol, and α-tocopherol were measured in 100 uL of plasma by high performance liquid 
chromatography using a modified method from the Nutrition Laboratory, Inorganic Toxicology 
and Nutrition Branch Division of Laboratory Sciences, National Center of Environmental 
Health, Centers of Disease Control and Prevention.20,21  Quality control was assessed by repeated 
analysis of pooled human plasma controls run at the beginning and the end of each analysis. 
Standard curves were run periodically using standard reference material 986C (National Institute 
of Standards and Technology, Gaithersburg, MD). 
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Plasma trace element concentrations were measured using a Perkin Elmer model AAnalyst 
600 atomic absorption spectrometer equipped with Zeeman background correction, a THGA 
graphite furnace, and an AS800 auto sampler (Perkin Elmer Corp., Norwalk, CT).  For both 
selenium and zinc, two pooled human plasma controls, which were run at the beginning and end 
of each batch of samples, as well as “Seronorm” Trace Elements Serum (Accurate Chemical and 
Scientific Corp., Westbury, NY, USA), which was run periodically throughout the analysis, were 
used to determine within and between run CV.  Throughout all analyses, the plasma samples 
were run in a masked fashion.  Due to the unavailability of some sample aliquots, plasma 
erythropoietin, ferritin, IL-6, zinc, and HIV load could not be measured in 2, 1, 1, 1, and 16 
samples respectively. 
Statistical analysis  
Anemia was defined as hemoglobin concentrations<120 g/L for females and <130 g/L for 
males, as per convention.10  Moderate to severe anemia was defined as hemoglobin 
concentrations <80 g/L for both sexes according to the AIDS Clinical Trials Group 
classification.22  Iron deficiency was defined as plasma ferritin concentrations <30 µg/L. We 
have chosen this cut-off based on earlier work in Malawi.23 This higher cut-off was shown to be 
appropriate in an HIV infected population with elevated concentrations of acute phase proteins. 
Because there is no standard cut-off for elevated plasma IL-6 concentrations, we divided plasma 
IL-6 into tertiles and made comparisons of the highest two tertiles of IL-6 with the lowest tertile, 
where tertiles were defined as lowest (< 15.0 pg/mL), middle (> 15.0 to < 40.0 pg/mL), and 
highest (> 40.0 pg/mL).  Vitamin A deficiency was defined as plasma retinol concentrations 
<0.70 µmol/L, vitamin E deficiency as plasma α-tocopherol concentrations <11.6 µmol/L, zinc 
deficiency as plasma zinc concentrations <10.71 µmol/L and selenium deficiency as plasma 
selenium concentrations <0.89 µmol/L.24  Total plasma carotenoids were defined as the sum of 
α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein and zeaxanthin in µmol/L.  Provitamin 
A carotenoids were defined as the sum of α-carotene, β-carotene, and β-cryptoxanthin.  Non-
provitamin A carotenoids were defined as the sum of lycopene, lutein and zeaxanthin.  
Comparisons of categorical data were made using χ-square tests. Comparisons between 
continuous variables were made using univariate analysis of variance. One-way analysis of 
variance was applied to test for linearity.  Appropriate variable transformations were made to 
reduce skewness of data, such as log10 transformation for concentrations of erythropoietin, IL-6, 
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retinol, total carotenoids, α-tocopherol, zinc, and HIV load. Geometric means were shown for 
skewed data were applicable.   
A linear regression model was used to compare the relationship between plasma 
erythropoietin and hemoglobin concentrations among adults who were in the lowest and two 
highest tertiles of plasma IL-6, and among adults with and without HIV infection.  Univariate 
and multivariate logistic regression models were fitted with moderate to severe anemia as the 
outcome variable. Linear regression models were used to validate the associations. A 
significance level of P <0.05 was used in this study.  Statistical analyses were conducted using 
software packages SAS 8.01 (SAS Institute Cary, NC, USA) and SPSS 9.0 (SPSS, Inc., Chicago, 
IL, USA).  The protocol was approved by the institutional review boards at the Johns Hopkins 
School of Medicine in Baltimore, MD and the College of Medicine, University of Malawi in 
Blantyre, Malawi, with final approval by the Office for Protection from Research Risk of the 
National Institutes of Health, Bethesda, MD. 
 
Results 
The study population consisted of 370 HIV-positive and 130 HIV-negative adults with 
sputum-positive pulmonary tuberculosis.  Among the total study population, 69% (156/227) of 
male and 78% (214/273) of female participants were HIV-positive. The mean age among HIV-
positive and HIV-negative individuals was 34 and 32, respectively (P=0.05).  Mean hemoglobin 
concentrations among HIV-positive and HIV-negative individuals was 93.8 g/L and 106.6 g/L, 
respectively (P=0.0001).  Among HIV-positive and HIV-negative adults, the prevalence of 
anemia was 88.4% and 76.9%, respectively (P=0.002).  Moderate to severe anemia occurred in 
30.0% of HIV-positive versus 14.6% of HIV-negative adults (P=0.001). The majority of subjects 
were wasted, as 56% of subjects had a BMI <18.5.  Geometric mean plasma ferritin 
concentrations among HIV-positive and HIV-negative adults was 248.6 and 119.4 µg/L, 
respectively (P=0.001)  Among HIV-positive and HIV-negative adults, iron deficiency, defined 
as plasma ferritin concentrations <30µg/L, occurred in 5% and 12%, respectively (P=0.009).  
Geometric mean IL-6 concentration was 21.1 pg/mL, with no difference between HIV-positive 
and HIV-negative subjects.  Vitamin A, E, zinc, and selenium concentrations considered 
consistent with deficiency, occurred in 59%, 12%, 80% and 88% of all subjects, respectively, 
with no significant differences between HIV-positive and HIV-negative subjects.  
Characteristics, such as sex, mean age, BMI, plasma selenium concentrations, and geometric 
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mean plasma ferritin, erythropoietin, IL-6, micronutrient concentrations and HIV load of HIV-
negative and HIV positive individuals are shown by degree of anemia in Table 1 and Table 2, 
respectively.  Among both HIV-negative and HIV positive individuals BMI, plasma retinol, 
provitamin A carotenoids, non provitamin A carotenoids, total carotenoids and selenium 
concentrations decreased by increasing degree of anemia. Plasma ferritin, erythropoietin, IL-6, 
and the proportion of individuals with vitamin A and selenium deficiency were increased with 
increasing degree of anemia. In addition, among HIV-positive individuals, educational level was 
increasingly lower, and the proportion of individuals with BMI<18.5 and plasma HIV load were 
increasingly higher with increasing degree of anemia. 
The relationship between log10 plasma erythropoietin and hemoglobin concentrations 
among those in the highest two tertiles versus the lowest tertile of IL-6 was examined.  The 
regression lines were log10 plasma erythropoietin = 2.18 – 0.07 * hemoglobin for those in the 
highest two tertiles of IL-6 and log10 plasma erythropoietin = 1.88 – 0.06 * hemoglobin for those 
in the lowest tertile of IL-6.  The slopes of the regression lines between log10 plasma 
erythropoietin and hemoglobin among adults in the lowest tertile versus the higher two tertiles of 
IL-6 were not different (P= 0.49).  The relationship between log10 erythropoietin and hemoglobin 
concentrations was also compared between HIV-positive and HIV-negative adults with 
pulmonary tuberculosis.  The regression lines were log10 plasma erythropoietin = 2.22 – 0.08 * 
hemoglobin for HIV-positive adults and log10 plasma erythropoietin = 2.15 – 0.07 * hemoglobin 
for HIV-negative adults.  The slopes of the regression line between log10 plasma erythropoietin 
and hemoglobin were not significantly different between HIV-positive and HIV-negative adults 
with pulmonary tuberculosis (P= 0.36).   
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Table 1. Characteristics of HIV negative adults with pulmonary tuberculosis in Zomba, Malawi, 
with and without anemia 
Characteristic1 No anemia2 
 
(n = 30) 
Mild to moderate 
anemia3 
(n = 81) 
Moderate to severe 
anemia4 
(n = 19) 
P-value 
Sex (% Female) 33.3 49.4 47.4 0.25 
Age (years) 32 + 10 32 + 12 30 + 11 0.55 
Primary education or higher (%) 46.7 34.6 47.4 0.84 
Body mass index (wt/ht2) 19.8 + 2.7 18.5 + 2.9 17.7 + 2.6 0.009 
Wasting, body mass index <18.5 (%) 36.7 60.5 57.9 0.08 
Ferritin (µg/L) 69.9 (27.5,173.8) 141.12 (44.7,446.7) 136.58 (43.7,436.5) 0.05 
Iron deficiency, ferritin <30 µg/L (%)   23.3 8.6 10.5 0.11 
Erythropoietin (mU/mL) 18.5 (5.8,58.9) 24.5 (7.8,77.6) 71.2 (22.4,223.9) 0.003 
IL-6 (pg/mL) 5.6 (0.9,35.5) 30.9 (12.3,77.6) 28.1 (11.2,70.8) 0.007 
Retinol (µmol/L) 1.01 (0.58,1.76) 0.54 (0.32,0.92) 0.54 (0.29,1.00) 0.001 
Vitamin A deficiency, retinol <0.70 µmol/L (%) 23.3 67.9 68.4 0.001 
Provitamin A carotenoids (µmol/L) 0.36 (0.19,0.71) 0.26 (0.11,0.64) 0.22 (0.09,0.54) 0.02 
Non-provitamin A carotenoids (µmol/L) 0.62 (0.42,0.92) 0.43 (0.26,0.69) 0.41 (0.22,0.79) 0.001 
Total carotenoids (µmol/L) 1.02 (0.67,1.55) 0.72 (0.43,1.19) 0.65 (0.32,1.32) 0.002 
α-Tocopherol (µmol/L) 16.0 (11.9,21.6) 15.0 (11.7,19.4) 17.9 (14.3,22.6) 0.35 
Vitamin E deficiency, α-tocopherol <11.6 µmol/L (%) 13.3 14.8 5.2 0.51 
Zinc (µmol/L) 9.8 (8.2,11.8) 8.4 (6.4,11.1) 8.9 (6.9,11.5) 0.12 
Zinc deficiency, zinc <10.71 µmol/L (%) 77.5 73.7 76.9 0.72 
Selenium (µmol/L)  0.729 + 0.23 0.639 + 0.25 0.554 + 0.22 0.01 
Selenium deficiency, selenium <0.89 µmol/L (%) 73.3 85.2 94.7 0.04 
1 Mean ±SD for continues variables with normal distribution, geometric mean (lower, upper SD) when distribution was not normal.  
2 Hemoglobin >120 g/L for females and >130 g/L for males. 
3 Hemoglobin <120 g/L for females and <130 g/L for males, and > 80 g/L for both sexes. 
4 Hemoglobin < 80 g/L for both sexes. 
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Table 2. Characteristics of HIV positive adults with pulmonary tuberculosis in Zomba, Malawi, 
with and without anemia  
Characteristic1 No anemia2 
 
(n = 43) 
Mild to moderate 
anemia3 
(n = 216) 
Moderate to severe 
anemia4 
(n = 111) 
P-value 
Sex (% Female) 65.1 52.8 64.9 0.43 
Age (years) 32 + 8 34 + 9 34 + 8 0.33 
Primary education or higher (%) 55.8 48.6 34.2 0.005 
Body mass index (wt/ht2) 19.9 + 3.1 18.5 + 2.8 17.6 + 2.2 0.001 
Wasting, body mass index <18.5 (%) 39.5 54.2 69.4 0.001 
Ferritin (µg/L)* 132.3 (41.7,416.9) 226.1 (70.8,708.0) 381.6 (151.4,955.0) 0.001 
Iron deficiency, ferritin <30 µg/L (%) 9.3 6.0 2.7 0.08 
Erythropoietin (mU/mL)*  18.9 (6.0,60.3) 20.1 (6.3,63.1) 55.6 (17.8,177.8) 0.001 
IL-6 (mU/mL)* 11.4 (2.9,45.7) 19.1 (6.0,60.3) 33.3 (13.2,83.2) 0.001 
Retinol (µmol/L) 0.71 (0.37,1.36) 0.64 (0.35,1.20) 0.47 (0.12,1.91) 0.001 
Vitamin A deficiency, retinol <0.70 µmol/L (%) 46.5 53.2 75.7 0.001 
Provitamin A carotenoids (µmol/L) 0.28(0.12,0.64) 0.24(0.11,0.54) 0.20(0.09,0.47) 0.02 
Non-provitamin A carotenoids (µmol/L) 0.47 (0.27,0.82) 0.40 (0.24,0.69) 0.32 (0.19,0.55) 0.001 
Total carotenoids (µmol/L) 0.78 (0.42,1.45) 0.68 (0.38,1.20) 0.55 (0.30,1.00) 0.002 
α-Tocopherol (µmol/L) 15.9 (12.1,20.9) 16.0 (11.8,21.5) 16.8 (12.2,23.2) 0.20 
Vitamin E deficiency, α-tocopherol <11.6 µmol/L (%) 4.6 11.6 11.1 0.23 
Zinc (µmol/L) 9.8 (7.5,12.9) 8.5 (6.3,11.5) 8.5 (6.3,11.5) 0.09 
Zinc deficiency, zinc <10.71 µmol/L (%) 83.0 77.5 81.3 0.22 
Selenium (µmol/L)  0.724 + 0.22 0.633 + 0.20 0.513 + 0.20 0.001 
Selenium deficiency, selenium <0.89 µmol/L (%) 79.1 90.3 94.6 0.006 
Log10 HIV load (copies *103/mL)* 77.3 (9.8,616.6) 169.0 (44.7,7.7.9) 298.0 993.3,933.3) 0.001 
1 Mean ±SD for continuous variables with normal distribution, geometric mean (lower, upper SD) when distribution was not normal  
2 Hemoglobin >120 g/L for females and >130 g/L for males 
3 Hemoglobin > 80 g/L to <120 g/L for females and > 80 g/L to <130 g/L for males 
4 Hemoglobin < 80 g/L for both sexes 
* Ferritin, Erythropoietin, IL-6, zinc and HIV load was not measured in 1,2,1,1 and 16 HIV-positive subjects, respectively.  
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 Univariate and multivariate logistic regression models were used to examine the 
relationship between, age, sex, BMI, plasma ferritin, IL-6, micronutrient concentrations, and 
HIV load, with moderate to severe anemia (Table 3).  In univariate models, sex, BMI, IL-6, 
retinol, total carotenoids, selenium, and HIV load were significantly associated with moderate to 
severe anemia.  In multivariate logistic analysis, low plasma selenium concentrations and high 
HIV load were independently associated with moderate to severe anemia.  In a final multivariate 
linear regression model that adjusted for BMI, micronutrient concentrations, sex and age; log10 
IL-6 (P=0.03) and log10HIV load (P=0.001) were negatively associated with hemoglobin 
concentrations, whereas plasma selenium (P=0.0001) was positively associated with hemoglobin 
concentrations.  
 
 
 
Table 3. Risk factors for moderate to severe anemia1 in adults with pulmonary tuberculosis  
with and without HIV co-infection.   
Risk Factor Univariate O.R. (95% C.I.) P-value Multivariate O.R. (95% C.I.)* P-value 
Male sex  0.65 (0.43-0.98) 0.04 0.63 (0.34-1.12) 0.12 
Age (per year) 0.99 (0.98-1.02) 0.90 1.01 (0.98-1.04) 0.58 
Body mass index (wt/ht2) 0.85 (0.78-0.92) 0.001 1.02 (0.91-1.13) 0.76 
Log10 IL-6 (mU/mL) 3.02 (1.90-4.80) 0.001 1.97 (0.84-4.63) 0.12 
Log10 Retinol (µmol/L) 0.16 (0.07-0.34) 0.001 0.46 (0.12-1.84) 0.27 
Log10 Total carotenoids (µmol/L) 0.20 (0.09-0.43) 0.001 0.61 (0.18-2.07) 0.43 
Log10 α-Tocopherol (µmol/L) 6.83 (1.40-33.21) 0.02 7.02 (0.83-59.45) 0.07 
Log10 Zinc (µmol/L) 0.65 (0.13-3.24) 0.60 1.45 (0.19-10.81) 0.72 
Selenium (µmol/L) 0.04 (0.01-0.13) 0.001 0.10 (0.03-0.41) 0.001 
Log10 HIV load (copies *103/mL)  2.83 (1.73-4.63) 0.001 2.05 (1.21-3.50) 0.008 
1 Hemoglobin < 80 g/L for both sexes. 
* adjusted for all other variables in the model. 
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Discussion 
This study suggests that there is an association between low selenium concentrations and 
anemia. The prevalence of anemia is extremely high among adults with pulmonary tuberculosis 
in Malawi, as 88% of HIV-positive adults and 77% of HIV-negative adults were anemic.  In 
comparison, 60% of malnourished tuberculosis patients with unknown HIV status were anemic 
in Indonesia5, and 71% of adults co-infected with tuberculosis and HIV were anemic in Uganda.6  
The relatively higher prevalence of anemia in Malawi is consistent with the observation that 
malnutrition and wasting are also higher in this study population compared with other 
populations of adults with pulmonary tuberculosis (van Lettow et al. 2004, submitted). 
In this study we demonstrate an association between selenium deficiency and anemia in 
adults with pulmonary tuberculosis. Selenium is contained in glutathione peroxidase, an enzyme 
that plays a major role in protection against free radicals and oxidative stress.25,26  Dietary 
selenium markedly increased activity of plasma glutathione peroxidase in rat erythrocytes. 
Accordingly, higher concentrations of selenium in rat erythrocytes were considered to be 
responsible for increased resistance against oxidative stress.27  
Selenium deficiency may potentially contribute to anemia through increased oxidative 
stress, but further studies are needed to confirm the association between selenium deficiency and 
anemia in adults with pulmonary tuberculosis. 
It was difficult in this study to assess iron deficiency using plasma ferritin in these 
subjects, as ferritin is a positive acute phase reactant.28  Many subjects with pulmonary 
tuberculosis had evidence of an acute phase response, as reflected by elevated IL-6 
concentrations.  Thus, the prevalence of iron deficiency, as measured by plasma ferritin in this 
study, is probably greatly underestimated.  Iron deficiency and iron deficiency anemia are known 
to be common among women in Malawi 23, and this is consistent with our observation in 
univariate analysis that women were at higher risk of anemia than men.  A limitation of our 
study is that malaria parasitemia was not assessed in all subjects at enrollment.  Malaria is 
endemic in this study population, but there was no justification from a clinical standpoint at the 
time of enrollment to perform malaria smears on all patients who were commencing therapy for 
pulmonary tuberculosis. 
 Although wasting, as shown by low BMI, was associated with moderate to severe anemia 
in univariate analyses, this relationship was no longer significant after adjusting for sex, age, 
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plasma HIV load, IL-6 and micronutrient concentrations.  Similarly, antioxidant nutrients such as 
plasma carotenoids, retinol, and α-tocopherol concentrations were associated with moderate to 
severe anemia in univariate analyses, but these relationships were no longer significant after 
adjusting for BMI, sex, age, plasma HIV load, IL-6 and micronutrient concentrations.  
Inflammation, as reflected by IL-6 concentrations, was not associated with moderate to severe 
anemia in multivariate logistic analysis. However, in multivariate linear regression analysis that 
adjusted for sex, age, BMI, plasma HIV load, and micronutrient concentrations; IL-6 was 
associated with hemoglobin concentrations. We may therefore conclude that the anemia of 
infection does partly account for the anemia found in tuberculosis. There is evidence from 
Malawi that patients with tuberculosis may have asymptomatic bacteraemia.29 
To our knowledge, this is the first study to characterize the erythropoietin response to 
anemia among HIV-positive adults with pulmonary tuberculosis.  This study shows that the 
erythropoietin response to anemia was not different between adults with elevated IL-6 and those 
with lower IL-6 concentrations.  One study from South Africa described a blunted response to 
erythropoietin among adults with pulmonary tuberculosis, when comparing with matched 
individual with uncomplicated iron deficiency.30 The blunted response was explained by the 
inhibitory effects of inflammatory cytokines. In the present study all individuals had relatively 
high levels of inflammation, which could explain that we did not find any difference between 
adults with elevated IL-6 and those with lower but still relatively high IL-6 concentrations.  
Similarly, there were no differences in the erythropoietin response to anemia between 
HIV-positive and HIV-negative adults with pulmonary tuberculosis.  This is in contrast with 
previous studies that have shown a blunted erythropoietin response to anemia in HIV-positive 
compared with HIV-negative adults.13,14  One possible explanation is that both HIV-positive and 
HIV-negative adults had high levels of inflammation at the time of commencement of 
tuberculosis chemotherapy in the present study, and that the inflammation associated with 
tuberculosis and HIV co-infection, rather than HIV seropositivity alone, is the main factor in 
suppressing the erythropoietin response to anemia.  
Anemia might be a secondary effect of a chronic disease such as tuberculosis and its 
socio-economic implications that lead to inadequate dietary intake.   It likely that iron and folate 
deficiencies contribute to the anemia in HIV and tuberculosis, and further studies are needed to 
gain insight into this issue. 
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Despite important advances in HIV therapies and treatment of associated infections, the 
prevalence of anemia does not appear to have changed greatly over the last several years.31  
Anemia is one of the most common but neglected problems associated with HIV infection 31, and 
the present study shows that the anemia can be especially severe with tuberculosis and HIV co-
infection.  High mortality is the most important challenge facing tuberculosis programs in sub-
Saharan Africa and it is likely that anemia plays an important role in this event.  This study 
shows that there is an association between high HIV load and anemia. Early recognition of HIV 
through voluntarily counselling and testing and ultimately highly active antiretroviral treatment 
are important ways towards addressing this problem.  A recent study from Uganda, showed 
evidence that cotrimoxazole had stabilizing effects on HIV load and CD4-cell counts.32  Daily 
cotrimoxazole prophylaxis was associated with reduced mortality and has been recommended as 
a basic component of Tuberculosis and HIV care throughout Africa.32,33  Recombinant 
erythropoietin therapy has been shown to be effective in treating the anemia associated with HIV 
infection, however, the cost of the medication alone for a usual 12-week treatment can be U.S. 
$4,000-5,000, which is beyond the resources of many in developing countries.  Other strategies, 
such as micronutrient supplementation, are inexpensive strategies that need further evaluation as 
possible approaches for the anemia associated with pulmonary tuberculosis and HIV infection. 
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Abstract 
Wasting is a prominent feature of tuberculosis and may be more severe among individuals with 
human immunodeficiency virus (HIV) co-infection.  It is likely that several biological 
mechanisms, including the anorexia of infection are contributing to wasting. The purpose of this 
study was to determine whether leptin concentrations, in relation to the inflammatory cytokine 
response and level of HIV infection, are contributing to loss of appetite and wasting in adults 
with pulmonary tuberculosis and HIV infection. We characterized plasma leptin concentrations 
in relationship with self-reported loss of appetite, body mass index (BMI), fat mass (FM), 
interleukin-6 (IL-6) and HIV load in a cross-sectional study of 500 adults who presented with 
pulmonary tuberculosis in Zomba, Malawi. Plasma leptin concentrations, associated with FM, 
significantly decreased by increasing tertile of plasma HIV load (P=0.0001). Leptin 
concentrations were inversely associated with plasma IL-6 concentrations after adjusting for sex, 
age, FM and HIV load. Plasma leptin concentrations were neither associated with loss of appetite 
nor with wasting. Inflammation, reflected by increased IL-6 concentrations, was associated with 
loss of appetite (OR = 3.41; 95% confidence interval [CI], 1.91-6.09), when adjusted for sex, 
age, FM, leptin concentrations and HIV load. A high plasma HIV-load was associated with 
severe wasting, defined as BMI<16.0 (OR = 2.14; 95% CI, 1.09-4.19), when adjusted for sex, 
age, IL-6, FM and leptin concentrations.  
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Introduction 
Tuberculosis has re-emerged with the acquired immune deficiency (AIDS) pandemic to 
become the world’s leading cause of death from a single infectious agent, accounting for a 
quarter of the avoidable adult deaths in the developing world.1,2 Wasting is a prominent feature 
of tuberculosis and is probably one of the determinants of disease severity and outcome. Co-
infection with human immunodeficiency virus (HIV) and tuberculosis may worsen the wasting 
seen in tuberculosis or HIV infection alone.3 It is likely that several biological mechanisms, 
including the anorexia of infection are contributing to wasting. Inflammatory cytokines are 
principal candidates as mediator of the metabolic changes resulting in tuberculosis-associated 
wasting. Inflammatory cytokines trigger the host's acute phase response (APR) and possibly also 
the anorexia during infections.4 Several microbial products, as well as leptin and cytokines 
reduce food intake after parental administration, suggesting a role of these substances in the 
anorexia of infection.4,5 
The fat-derived hormone leptin is best known as a key mediator of energy metabolism.6 
High leptin concentrations signal the presence of sufficient energy stores to the hypothalamus, 
which respond by reducing appetite and increasing energy expenditure. Leptin concentrations are 
proportional to fat mass and are reduced in starvation.7 In addition, leptin is now also recognized 
as both a recipient and an effector of immune stimuli, belonging to the same class of cytokines as 
interleukin-6 (IL-6).8 Animal studies have suggested that leptin mediates anorexia in chronic 
inflammatory states.9  On these bases, leptin may be involved in the cross-regulation between 
nutritional status and the immune response in tuberculosis.  
Leptin concentrations may be low, as a result of low body fat in tuberculosis, or high as a 
result of the host inflammatory response. High leptin concentrations in tuberculosis patients, 
could suppress appetite and food intake, which could be one of the contributing factors of weight 
loss and wasting. Low leptin concentrations may suppress immunity and worsen disease 
outcome. Two studies from Turkey suggested high leptin concentration in adults with 
tuberculosis10,11, while one study from Indonesia found low leptin concentrations in adults with 
tuberculosis.12  
The role of leptin and the inflammatory cytokine response in the anorexia and wasting of 
patients with tuberculosis and HIV infection has not been characterized. The purpose of this 
study was to characterize plasma leptin concentrations in HIV-infected and uninfected adults 
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with pulmonary tuberculosis, in relation to nutritional status, level of inflammation and level of 
HIV-infection. Moreover, we aimed to determine whether leptin concentrations, in relation to 
inflammation and level of HIV infection are contributing to loss of appetite and wasting.  
To address these objectives, we characterized plasma leptin concentrations in relationship 
with self-reported loss of appetite, body mass index (BMI), fat mass (FM) derived from 
bioelectrical impedance analysis (BIA), plasma interleukin-6 (IL-6), and plasma HIV load in a 
cross-sectional study of 500 adults who presented with pulmonary tuberculosis in Zomba, 
Malawi.   
 
Methods 
The study population consisted of 500 adults who presented with new sputum-positive 
pulmonary tuberculosis in Zomba Central Hospital between July 1999 and September 2001. This 
cross-sectional sample was drawn from a micronutrient supplementation study. Subjects were 
offered HIV testing and were screened for HIV antibodies after written informed consent.  All 
subjects were given appropriate pre- and post-test HIV counselling.  Subjects received standard 
short course chemotherapy for tuberculosis as per guidelines of the Malawi National 
Tuberculosis Program.13  Adults with a previous history of treated pulmonary tuberculosis were 
excluded.  Three sputum samples from each subject were examined with Auramine-O dark-
fluorescent staining method.  Sputum-positive pulmonary tuberculosis was considered proven 
when at least one out of three sputum stains showed acid-fast bacilli.  HIV infection was 
diagnosed on the basis of a positive rapid test (Determine 1/2 Rapid test by Abbott, Abbott 
Laboratories, Johannesburg, SA) and confirmed by a positive enzyme-linked immunosorbent 
assay for HIV-1 antibodies (Wellcozyme; Wellcome Diagnostics, Dartford, Kent, UK).  
Body weight was determined to the nearest 0.1 kg using an adult balance (Seca 700 
balance, Seca Corporation, Hanover, MD, USA), and standing height was determined to the 
nearest cm.  Wasting was defined as BMI (wt/ht2) <18.5, and severe wasting as BMI <16.0, 
conform the WHO strata for BMI grading for severity of malnutrition.14   
Single-frequency BIA was performed at 50 kHz and 800 µA (RJL Systems, Inc., Detroit, MI, 
USA) with standard tetrapolar lead placement. BIA measurements were performed in triplicate 
for each subject.  The reproducibility on repeated BIA measurements was >99%. To calculate 
FM and body cell mass (BCM), equations were used that were validated in a sample of adults 
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with and without HIV-infection.15,16. A standard questionnaire, with closed questions, was used 
to determine loss of weight and loss of appetite. Loss of appetite was considered positive when 
the subject gave loss of appetite as a reason for the observed loss of weight in the lost month.  
Blood samples were obtained by venipuncture (Sarstedt Monovette, Newton, NC) at initial 
diagnosis of tuberculosis. Subjects were not asked about prior food intake. Aliquots of plasma 
were made in trace element-free cryovials, and samples were stored in liquid nitrogen. Plasma 
samples were kept in liquid nitrogen or at –70º C until the time of laboratory analyses.  Plasma 
HIV load was measured using quantitative HIV-1 RNA PCR (Roche Amplicor Monitor, version 
1.5, Branchburg, NJ, USA) with a sensitivity limit of 400 HIV RNA copies mL.  
Plasma leptin concentrations were measured by ELISA using R&D Systems,Inc., Human 
Leptin Quantikine Colorimetric Sandwich ELISA kit (Minneapolis, MN, USA).  Plasma IL-6 
concentrations were measured by ELISA. (Human IL-6, R & D Systems, Minneapolis, MN.  
Quality control was assessed by repeated analysis of pooled human plasma controls run at the 
beginning and the end of each analysis. Standard curves were run periodically using standard 
reference material 986C (National Institute of Standards and Technology, Gaithersburg, MD). 
Throughout all analyses, the plasma samples were run in a masked fashion.  Due to the 
unavailability of some sample aliquots, plasma IL-6 and HIV load could not be measured in 1 
and 16 samples respectively. 
Comparisons of categorical data were made using χ-square tests. Comparisons between 
continuous variables were made using t-tests.  Appropriate variable transformations were made 
to reduce the skewness of the data, such as log10 transformation for leptin, IL-6 and HIV load. 
Univariate analysis of variance was used to test for linear trends of plasma leptin concentrations 
across categories of plasma HIV load. Linear regression models were used to explore the 
relationships between plasma leptin concentrations and FM, IL-6 and HIV load. Univariate and 
multivariate logistic regression models were used to evaluate determinants of self-reported loss 
of appetite, and to evaluate associations with severe wasting.  
A significance level of P <0.05 was used in this study.  Statistical analyses were 
conducted using software packages SAS 8.01 (SAS Institute Cary, NC, USA) en SPSS 9.0 
(SPSS, Inc., Chicago, IL, USA).  The protocol was approved by the institutional review boards at 
the Johns Hopkins School of Medicine in Baltimore, MD and the College of Medicine, 
University of Malawi in Blantyre, Malawi, with final approval by the Office for Protection from 
Research Risk of the National Institutes of Health, Bethesda, MD. 
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Results 
The study population consisted of 370 HIV-positive and 130 HIV-negative adults with 
sputum-positive pulmonary tuberculosis.  Of all participants, 69% (156/227) of men and 78% 
(214/273) of women were HIV-positive. Table 1 shows characteristics of study participants by 
sex and HIV status; such as age, body composition, IL-6, HIV load and plasma leptin 
concentrations.  
 
 
Table 1. Characteristics of adults with and without human immunodeficiency virus (HIV) 
infection presenting with pulmonary tuberculosis in Zomba, Malawi 
Characteristic1 Male P-value Female P-value 2 
 HIV-negative 
n = 71 
HIV-positive 
n = 156 
 HIV-negative 
n = 59 
HIV-positive 
n = 214 
 
Age (years) 33.1 + 11.6 36.0 + 7.9 0.03 30.5 + 11.2 32.2 + 8.6 0.18 
Loss of appetite (% reported) 22.5 39.7 0.01 28.8 41.1 0.24 
Loss of weight  (% reported) 74.6 81.4 0.30 81.4 86.9 0.24 
Body mass index (wt/ht2) 18.7 + 3.1 18.5 + 2.6 0.58 18.6 + 2.7 18.3 + 2.8 0.40 
Wasting, body mass index <18.5 (%) 54.9 54.5 0.95 54.2 58.4 0.57 
Wasting, body mass index <16.0 (%) 14.7 12.7 0.84 21.0 10.2 0.06 
Body cell mass (% of weight) 41.0 + 3.8 39.4 + 3.1 0.001 33.6 + 3.2 33.2 + 3.2 0.39 
Fat mass (% of weight) 7.2 + 4.8 7.4 + 5.2 0.81 19.9 + 8.8 19.0 + 8.7 0.49 
Log10 IL-6 (pg/mL) 1.28 + 0.6 1.32 + 0.5 0.54 1.36 + 0.5 1.33 + 0.5 0.67 
Log10 HIV load __ 5.32 + 0.5  __ 5.22 + 0.6  
Log10 Leptin (pg/mL) 2.45 + 0.5 2.33 + 0.6 0.17 3.12 + 0.6 3.02 + 0.5 0.20 
1 Mean ±SD for continues variables; 2 P-values assessed by t-tests for continuous variables, χ-square tests for categorical data. 
3 Hemoglobin <120 g/L for females and <130 g/L for males 
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When comparing men and women (data not shown), men were older and had lower FM 
(P=0.0001), log10 leptin concentrations (P=0.0001) and higher BCM (P=0.0001) than women.  
There was no difference in BMI or the proportion of individuals with wasting between men and 
women. There was no difference in mean log10 IL-6 concentrations between men and women, 
and no difference in mean log10 HIV load between male and female HIV-positive adults.  
 
Figures 1 shows plasma leptin concentrations with 95% C.I by sex and categories of 
plasma HIV load. This figure illustrates that plasma leptin concentrations were not different 
between HIV negative subjects and HIV positive subjects in the lowest tertile of HIV load. 
However, plasma leptin concentrations significantly decreased by increasing tertile of plasma 
HIV load.  
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Fig 1. Log-transformed mean plasma leptin concentrations with 95% C.I. are depicted by sex and plasma 
HIV load.  
Among all participants with pulmonary tuberculosis, men had significant lower log10 leptin 
concentrations than women. There was no significant difference in mean log10 leptin concentrations 
between HIV-negative individuals compared with HIV-positive individuals in the lowest tertile of HIV 
load. However, mean log10leptin concentrations significantly decreased with the increase of plasma HIV 
load, in both men and women  (P=0.0001 and P=0.01, respectively).  
 
96 
Table 2. Factors associated with plasma leptin concentrations  
in adults with pulmonary tuberculosis 
Variable Regression coefficient, β 
Univariate*  
95% CI P  Regression coefficient, β 
Multivariate* 
95% CI P 
Fat mass (% of weight) 5.00 4.57 – 5.43 0.0001 4.18 3.57 – 4.80 0.0001 
Log10 IL-6 (pg/mL) -0.34 -0.45 – -0.23 0.0001 -0.10 -0.18 – -0.01 0.02 
Log10 HIV Load  -0.28  -0.39 – -0.17 0.0001 -0.08 -0.07 – 0.01 0.06 
*Univariate and multivariate linear regression; adjusted for sex, age, and all other variables in the model. 
 
The linear relationships between plasma leptin concentrations and FM, IL-6 and HIV load 
are shown in Table 2. In order to determine an independent association of FM, inflammation and 
HIV infection with leptin concentrations, we examined the relationships in multivariate linear 
models that adjusted sex, age and all variables in the model. In univariate linear regression 
analysis, FM (P=0.0001) was positively correlated with log10 leptin concentrations, while log10 
IL-6 (P=0.0001) and log10 HIV load (P=0.0001) were inversely correlated with log10 leptin 
concentrations. In multivariate linear regression; that adjusted for sex, age and all other variables 
in the model, log10 leptin concentrations remained independently associated with FM (P=0.0001) 
and inversely with log10 IL-6 concentrations (P=0.02). The adjusted regression coefficient β for a 
linear association with log10 leptin concentrations was 4.18 (95% C.I.3.57 – 4.80) for FM and  
-0.10 (95% C.I.-0.18 – -0.01). for log10 IL-6 concentrations. The association between log10 HIV 
load with log10 leptin concentrations did not reach significance in multivariate analysis (P=0.06). 
 
Figure 2 shows that plasma leptin concentration increases proportionally with percentage 
of body fat. In univariate analysis, the fitted regression lines for male and female were log10 
leptin =1.86 +0.07 * fat mass and log10 leptin =2.26 +0.04 * fat mass, respectively, with a 
difference in the slope of the regression lines between log10 plasma leptin and fat mass among 
males and females (P= 0.001).  
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Fig 2. Relationship between log10 plasma leptin and percentage of body fat among males (squares, solid 
line) and females (circles, broken line) with pulmonary tuberculosis. The fitted regression lines were log10 
leptin =1.86 +0.07 * fat mass and log10 leptin =2.26 +0.04 * fat mass, respectively, with a difference in 
the slope of the regression lines between log10 plasma leptin and fat mass among males and females (P= 
0.001) 
 
 
Determinants of appetite and wasting 
The relationships between self-reported loss of appetite and plasma leptin concentrations, 
IL-6 and HIV load are shown in Table 3.  In order to determine which factors contribute to loss 
of appetite, we examined the relationships in multivariate logistic regression models that 
adjusted for sex, age, FM and all other variables in the model. This table shows that plasma 
leptin concentrations were not associated with loss of appetite. In univariate logistic regression 
analysis log10-IL-6 (P=0.0001) and log10 HIV load (P=0.03) were associated with loss of 
appetite. In multivariate logistic regression analysis only higher log10 IL-6 (P=0.0001) remained 
associated with loss of appetite. The adjusted O.R. for an independent association of log10 IL-6 
with loss of appetite was 3.41 (95% C.I. 1.91-6.09). 
 
 
 
98 
Table 3. Factors associated with self-reported loss of appetite  
in adults with pulmonary tuberculosis 
Risk Factor Univariate O.R. (95% C.I.) P-value Multivariate O.R. (95% C.I.)* P-value 
Log10 leptin (pg/mL) 0.82 (0.62-1.09) 0.17 1.06 (0.65-1.72) 0.81 
Log10 IL-6 2.60 (1.73-3.91) 0.0001 3.41 (1.91-6.09) 0.0001 
Log10 HIV load** 1.52 (1.04-2.23) 0.03 1.38 (0.90-2.12) 0.14 
Univariate and multivariate logistic analysis; adjusted for sex, age, FM and all other variables in the model. 
 
The relationships between severe wasting and plasma leptin concentrations, IL-6 and HIV 
load are shown in Table 4.  In order to determine which factors contribute to severe wasting, we 
examined the relationships in multivariate logistic regression models with severe wasting, 
defined as BMI<16, as the outcome variable.  In univariate analyses, log10 leptin (P=0.0001), 
log10 IL-6 (P=0.0001) and log10 HIV load (P=0.0006) were associated with severe wasting. In 
multivariate analysis that adjusted for sex, age, the interaction between leptin and FM, and all 
other variables in the model only higher HIV load (P=0.03) remained associated with severe 
wasting. The adjusted O.R. for an independent association of log10 HIV load with severe wasting 
was 2.14 (95% C.I. 1.09-4.19).  
 
Table 4. Factors associated with severe wasting (BMI<16.0)  
in adults with pulmonary tuberculosis 
Risk Factor Univariate O.R. (95% C.I.) P-value Multivariate O.R. (95% C.I.)* P-value 
Log10 leptin (pg/mL) 0.40 (0.28-0.59) 0.0001 1.00 (0.47-2.15) 0.99 
Log10 IL-6 3.71 (2.09-6.59) 0.0001 2.03 (0.93-4.42) 0.07 
Log10 HIV load** 3.03 (1.61-5.72) 0.0006 2.14 (1.09-4.19) 0.03 
* Univariate and multivariate logistic analysis; adjusted for sex, age, the interaction between FM and leptin and all 
other variables in the model.  
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Discussion 
This study demonstrates that plasma leptin concentrations are associated with FM and 
with the inflammatory cytokine (IL-6) response. Leptin reflected the percentage of FM and 
decreased with the increase of HIV load. Inflammation, characterized by IL-6 concentrations, 
was associated with loss of appetite, and level of HIV-replication, characterized by plasma HIV 
load, was associated with severe wasting. This study suggests that leptin does not account for the 
anorexia and weight loss in tuberculosis. The anorexia and wasting in patients with tuberculosis 
and HIV co-infection seem primarily determined by the level of inflammation and the level of 
HIV infection.  
The role of leptin in tuberculosis has been limited to adults without tuberculosis and HIV 
co-infection.10-12,17 In 30 patients with tuberculosis in Turkey, higher leptin concentrations were 
described among those with active tuberculosis compared with controls.10  Similar results were 
reported in another study from Turkey involving 25 patients with tuberculosis.11 One study from 
Indonesia, found lower leptin concentrations in 60 HIV-negative patients with active 
tuberculosis compared to 30 healthy controls.12  And in effect, leptin concentrations in the 
untreated tuberculosis patients from Indonesia were similarly low as those in our study. In the 
present study, plasma leptin concentrations were not different between HIV negative subjects 
and HIV positive subjects in the lowest tertile of HIV load. However, plasma leptin 
concentrations significantly decreased by increasing tertile of plasma HIV load. The lower leptin 
concentrations in tuberculosis patients with high plasma HIV load may simply be attributed to 
further deprived nutritional status, as body fat is the most important determinant of plasma leptin 
concentrations. This is consistent with the observation that the nutritional status in patients with 
pulmonary tuberculosis in Malawi significantly decreases by increasing HIV load. (van Lettow 
et al. 2004, in print) 
The study from Indonesia, reported a negative association between C-reactive protein 
(CRP) and leptin, while our study demonstrates a negative association between the inflammatory 
cytokine (IL-6) response and leptin concentrations in adults with pulmonary tuberculosis (with 
and without HIV infection). Experimental and animal studies have shown that inflammatory 
mediators are able to increase leptin production leptin.4,10,18,19 However, the acute inflammatory 
response is different from the more chronic inflammatory response in tuberculosis. The results 
from this study support the hypothesis of Van Crevel and colleagues12 that the prolonged 
inflammatory response in tuberculosis may deplete or “exhaust” leptin production.  
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Theoretically, decreased leptin concentrations could impair protective cellular immunity 
to Mycobacterium tuberculosis12, as leptin is necessary for an effective cell-mediated immune 
response.20 For instance, CD4 T lymphocyte activities are suboptimal in the absence of leptin.7,20 
The present study suggests that the inflammatory response may deplete leptin production, which 
theoretically suppresses immunity. Low leptin levels, as a result of poor nutritional status and 
chronic inflammatory response may be a contributing factor in suppressing the immune function 
and worsening the outcome of tuberculosis. Further studies are needed to clarify whether this 
hypothesis is true.  
Conversely, in theory, low plasma leptin concentrations should increase appetite and 
decrease energy expenditure. However, the present study shows that leptin was not associated 
with loss of appetite, after adjusting for other factors, and this finding reinforces the conclusion 
of Schwenk and colleagues17 that leptin does not account for the weight loss and anorexia in 
tuberculosis.  
We demonstrated that leptin concentrations were not, but IL-6 was associated with loss of 
appetite. Experimental studies showed that parenteral administration of cytokines (including IL-
6) reduce food intake, suggesting a role in the anorexia during infection.4,5 Further research is 
needed into the role of cytokines in the physiological control of eating and energy balance during 
acute and chronic infection.  
In conclusion, this study suggests that leptin does not play a role in the anorexia and 
wasting in tuberculosis, but that it may play a role as a mediator between nutritional status and 
host defense, which could explain thin people's susceptibility to tuberculosis or the link between 
malnutrition and disease outcome. In addition, IL-6 production was associated with loss of 
appetite. Current knowledge4 on the different mechanisms involved in the anorexia of infection 
suggests some therapeutic options for treatment, including substances that antagonize cytokine 
action in combination with nutritional support.  
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Tuberculosis has emerged as the second commonest cause of death from infectious 
disease worldwide, after HIV/AIDS, killing nearly 2 million people each year. Most cases occur 
in less-developed countries. The human immunodeficiency virus (HIV) is the greatest single risk 
factor for the development of active tuberculosis in adults. Hence, over the past decade, 
tuberculosis incidence has increased in Africa, mainly as a result of the burden of HIV infection.1  
The association between tuberculosis and wasting has long been recognized, and is 
probably one of the determinants of disease severity and outcome. Yet, little is known about the 
etiology of tuberculosis-associated wasting.  
The nutritional status in relation to disease of patients with pulmonary tuberculosis with 
and without HIV co-infection, form the basis of this thesis. The studies described in this thesis 
were carried out in newly diagnosed adult pulmonary tuberculosis patients in Zomba Central 
Hospital, in the Southern region of Malawi.   
 
In Chapter 1, a general introduction is given and an outline of the thesis. Tuberculosis is 
discussed as a communicable disease. Risk factors and magnitude of HIV co-infection are 
depicted, globally, in Africa and in particular in Malawi.  The “triple trouble” of tuberculosis, 
HIV and malnutrition is introduced.  This concept suggests that HIV and tuberculosis infection 
and malnutrition may put those affected at greater risk than those with any of the three 
conditions alone. Some information about Malawi is given and the study site is presented.  
 
In Chapter 2, a review is presented on the current state of knowledge regarding the 
nutritional status of patients co-infected with tuberculosis and HIV. Changes in nutrition 
indicators during chemotherapy for tuberculosis are described, and the relationship between 
nutrition and clinical outcomes are examined. In brief, several cross-sectional studies suggest 
that patients with tuberculosis suffer from deficiencies of vitamin A, thiamin, vitamin B6, folate, 
and vitamin E. Some deficiencies are more prevalent among HIV-infected adults than in those 
without HIV infection. Other overall findings were that protein-energy malnutrition and anemia 
are common among adults with tuberculosis and HIV infection. Several anthropometrical studies 
showed that body mass index (BMI) is lower in adults with pulmonary tuberculosis than in 
healthy controls.  Bioelectrical impedance analysis (BIA) has been used to examine the body 
composition in pulmonary tuberculosis patients, and overall, large differences in body 
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composition between HIV-positive and HIV-negative adults with pulmonary tuberculosis do not 
seem to be present. Several studies showed that nutritional indicators, such as anthropometric 
measurements, improve during chemotherapy for tuberculosis. In addition, hemoglobin 
concentrations appear to improve, while nutritional status appears to be an important determinant 
of clinical outcome during chemotherapy for tuberculosis. A number of studies have examined 
the role of nutritional supplements in tuberculosis and in HIV. The outcome of these studies are 
discussed.   
 
In Chapter 3, a study is presented that dealt with the question whether there is a 
relationship between malnutrition and the severity of lung damage in tuberculosis. In this study 
we related the extent of malnutrition to the extent of lung disease. Lung disease in chest 
radiographs was graded according to a conventional classification system. We found that among 
319 adults with pulmonary tuberculosis with or without HIV co-infection, BMI, fat mass, and 
phase angle (the angle between resistance and reactance, derived from BIA) were independently 
associated with increasing severity of lung disease, when adjusted for sex, age, and plasma HIV 
load. These results support the hypothesis that the severity of lung disease is associated with the 
extent of malnutrition in adults with pulmonary tuberculosis. 
 
In Chapter 4, a study is presented that tested the hypothesis that micronutrient 
malnutrition is associated with wasting and higher plasma HIV load in adults with tuberculosis.  
In a study involving 801 adults with pulmonary tuberculosis, we found that BMI, plasma retinol, 
carotenoid and selenium concentrations significantly decreased by increasing tertile of plasma 
HIV load.  There were no significant differences in plasma micronutrient concentrations between 
HIV-negative individuals and HIV-positive individuals with plasma HIV load <133 200 
copies/mL.  Plasma vitamin A concentrations <0.70 µmol/L occurred in 61%, and zinc and 
selenium deficiency occurred in 85% and 87% respectively.  Wasting, defined as BMI <18.5, 
was present in 59% of study participants and was independently associated with a higher risk of 
low carotenoids, and vitamin A and selenium deficiency. Severe wasting, defined as BMI<16.0 
showed the strongest associations with deficiencies in vitamin A, selenium and plasma 
carotenoids. These data demonstrate that wasting and higher HIV load in pulmonary tuberculosis 
are associated with micronutrient malnutrition. 
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In Chapter 5, a study is presented in which we assessed the antioxidant micronutrient 
status, IL-6 concentrations, and HIV load in relationship with anemia in adults with pulmonary 
tuberculosis.  We found that among 370 HIV-positive and 130 HIV-negative adults with 
pulmonary tuberculosis, the prevalence of anemia was 88% and 77%, respectively. Moderate to 
severe anemia (hemoglobin <80 g/L) occurred in 30% and 15%, respectively.  It was difficult to 
assess iron deficiency using plasma ferritin, as many subjects had evidence of an acute phase 
response, as reflected by elevated Interleukin-6 (IL-6) concentrations. Thus, the prevalence of 
iron deficiency in this study is probably greatly underestimated.  In a multivariate logistic 
regression model, HIV load and lower plasma selenium concentrations were associated with 
moderate to severe anemia. In a final multivariate linear regression model, HIV load, selenium 
and IL-6 were associated with hemoglobin concentrations. The results of this study suggest that 
low selenium concentrations, high HIV load and high IL-6 concentrations are associated with 
anemia in adults with pulmonary tuberculosis. 
 
In Chapter 6, a study is presented in which we investigated whether leptin concentrations, 
in relation to the inflammatory cytokine response and level of HIV infection, are contributing to 
loss of appetite and wasting in adults with pulmonary tuberculosis and HIV infection.  We found 
that among 500 adults with pulmonary tuberculosis, plasma leptin concentrations were 
associated with fat mass and inversely with the inflammatory cytokine (IL-6) response. Leptin 
reflected the percentage of fat mass and decreased with the increase of plasma HIV load. 
Inflammation, reflected by increased IL-6 concentrations, was associated with loss of appetite, 
and the level of HIV infection, reflected by plasma HIV load, was associated with severe 
wasting. Leptin concentrations were neither associated with loss of appetite nor with wasting. 
This study suggests that leptin does not play a role in the anorexia and wasting in tuberculosis, 
but that it may play a role as a mediator between nutritional status and host defense, which could 
explain thin people's susceptibility to tuberculosis or the link between malnutrition and disease 
outcome. 
 
In conclusion, both HIV-positive and HIV-negative adults with pulmonary tuberculosis 
were extremely malnourished as indicated by body composition and plasma micronutrient 
concentrations. A limitation of our findings is that we did not have a control group of healthy 
Malawian adults.  However, one earlier study from Malawi showed that BMI was significantly 
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lower in adults with pulmonary tuberculosis than in healthy controls.2   And in effect, mean BMI 
in male and female tuberculosis patients were similarly low as those in our studies.   
Nutritional status between HIV-negative and HIV-positive adults appeared similar.  
However, in a study involving 801 adults, we showed that nutritional status was similar between 
HIV-negative adults and HIV-positive adults who were in the lowest tertile of plasma HIV load; 
but that nutritional status significantly decrease by increasing HIV disease. Anemia, which may 
perhaps be seen as both an outcome and marker of malnutrition, was also especially severe in 
adults with tuberculosis and HIV co-infection. We can therefore conclude that co-infection with 
tuberculosis and HIV does exacerbate the malnutrition seen in tuberculosis infection alone.   
We used BMI and indices derived from BIA measurements to illustrate the body 
composition of adults with pulmonary tuberculosis.  One of the advantages of BIA over BMI 
alone is that BIA can differentiate the degree of body fat and body cell mass in individuals.  
However, BMI was still a sensitive indicator of malnutrition in our investigations and may be 
considered as an adequate indicator in resource-poor settings.   
The association between high plasma HIV load and micronutrient deficiencies was 
strongest for selenium and the major plasma carotenoids. This observation may be of potential 
importance because selenium deficiency has been associated with increased mortality during 
HIV infection.3  In our study population, selenium deficiency occurred in 90% of HIV-positive 
individuals, which may be the highest prevalence of selenium deficiency reported in HIV-
infected adults. Our data also suggested that there is an association between selenium deficiency 
and anemia in adults with tuberculosis. To our knowledge, this is the first study to demonstrate 
an association between selenium and hemoglobin concentrations. Selenium deficiency may 
potentially contribute to anemia through increased oxidative stress, but further studies are needed 
to confirm the association. It is unknown whether selenium supplementation could reduce 
morbidity and mortality in adults with pulmonary tuberculosis.  
We showed that poor carotenoid status is associated with both advanced HIV disease and with 
wasting. Carotenoids are among the most important dietary antioxidants found in human plasma. 
It is not known whether adults with pulmonary tuberculosis have low plasma carotenoid 
concentrations because of increased oxidative stress, or whether these individuals are merely 
unable to consume enough carotenoid-rich foods.  Further studies are needed to address dietary 
intake of carotenoids in adults with pulmonary tuberculosis.   
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Fig 1. Associations that may contribute to malnutrition and disease (severity) in tuberculosis and HIV co-
infection.  (n) = Chapter in this thesis that describes the examined association.  
 
 
 
 
Tuberculosis   
[lung disease]                     [acid fast bacilli]
HIV        [viral load] 
 
   4                                           Micronutrient deficiencies                                    
[Selenium] 
[Zinc] 
[Vitamin A] 
[Carotenoids] 
[Vitamin E] 
Wasting  
[Body mass index, fat mass and other] 
Altered Immunity 
Inflammation  
[IL-6] 
Anemia  
[Hb] 
Appetite 
Dietary intake 
Leptin 
109 
Figure 1 shows the associations discussed in this thesis that may contribute to 
malnutrition and (severity of) disease in tuberculosis and HIV co-infection. We demonstrated 
that malnutrition in pulmonary tuberculosis is associated with the severity of lung disease; that 
micronutrient concentrations are related to wasting; that micronutrient malnutrition, anemia and 
wasting are more severe in adults with pulmonary tuberculosis who have higher HIV load and 
that low selenium concentrations, high HIV load and high IL-6 concentrations are associated 
with anemia in adults with pulmonary tuberculosis. We showed that plasma leptin concentrations 
are associated with the percentage of fat mass and with the inflammatory cytokine response. We 
demonstrated that leptin was not, but IL-6 was, associated with loss of appetite and concluded 
that the anorexia and wasting in patients with tuberculosis seem primarily determined by the 
level of inflammation and the level of HIV infection. Yet, further research is needed into the role 
of cytokines in the physiological control of eating and energy balance in pulmonary tuberculosis.  
We hypothesized that low leptin levels, as a result of poor nutritional status and chronic 
inflammatory response may be a contributing factor in suppressing the immune function and 
worsening the outcome of tuberculosis. Further research is needed to clarify the mechanisms as 
well as the effects of malnutrition, in relation to immunity and disease outcome of tuberculosis.    
 
The outcome of our studies contribute to an increased understanding of the etiology of 
tuberculosis-associated wasting. However, the cross-sectional design of the studies presented in 
this thesis restrict our conclusions and do not provide information on associations between 
nutritional status and (re) activation of (latent) tuberculosis infection, or whether poor nutritional 
status is a predictor of more severe pulmonary tuberculosis.  Succeeding longitudinal studies are 
needed to clarify such associations.  
Considering that Malawi is one of the poorest countries in Sub-Saharan Africa, the 
nutritional status in this ill and impoverished patient group may be low merely because of low 
dietary intake.  Therefore, the link between tuberculosis, HIV, malnutrition and poverty should 
not be underestimated.  Malnutrition, attributable to poverty, may increase the risk or rate of 
progression of HIV and therefore indirectly predispose those with latent tuberculosis to active 
tuberculosis.4,5   
In our study population, both HIV-positive and HIV-negative adults with pulmonary 
tuberculosis were extremely micronutrient deficient. Micronutrient deficiencies associated with 
wasting, depleted leptin production, immune suppression, anemia, and increased oxidative stress 
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may results in increased morbidity and mortality. It is unknown whether nutritional interventions 
will slow progression of disease or reduce malnutrition associated with morbidity and mortality.  
Adults with pulmonary tuberculosis and advanced HIV disease are at the highest risk of more 
severe micronutrient malnutrition, suggesting that this subgroup might potentially benefit the 
greatest from nutritional interventions.  The controlled clinical trial currently in progress in our 
study population should help to provide insight into the role of micronutrient supplementation 
for adults with pulmonary tuberculosis.   
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Tuberculose, de infectieziekte die veroorzaakt wordt door Mycobacterium tuberculosis is, na 
AIDS, momenteel de belangrijkste doodsoorzaak door infectieziekten. Elk jaar sterven er 
wereldwijd bijna 2 miljoen mensen aan tuberculose, waarvan het overgrote deel in minder 
ontwikkelde landen. Het humane immunodeficiëntie virus (HIV), de verwekker van AIDS, 
vormt de grootste onafhankelijke risicofactor voor de ontwikkeling van actieve tuberculose bij 
volwassenen. Tuberculose komt de laatste decennia aanzienlijk meer voor in Afrika, 
hoofdzakelijk tengevolge van de HIV pandemie.1  
De relatie tussen tuberculose en ondervoeding is sinds lange tijd bekend. Ondervoeding  
is vermoedelijk één van de bepalende factoren voor de ernst en het klinisch verloop van ziekte. 
In tegenstelling tot wat algemeen wordt aangenomen, is er nog weinig bekend over de oorzaak 
van de met tuberculose gepaard gaande ondervoeding.  
De voedingstoestand van patiënten met longtuberculose, met en zonder HIV-infectie, 
vormt de basis van dit proefschrift. De onderzoeken die in dit proefschrift zijn beschreven 
werden uitgevoerd onder volwassen patiënten bij wie longtuberculose net was vastgesteld. Zij 
werden onderzocht in Zomba Central Hospital, in het zuidelijke deel van Malawi.  
 
In Hoofdstuk 1 wordt een algemene inleiding en een overzicht van de achtergronden van 
dit proefschrift beschreven. Tuberculose wordt beschreven als besmettelijke ziekte. 
Risicofactoren en de omvang van tevens aanwezige HIV-infectie (“co-infectie”) worden 
besproken, mondiaal, in Afrika, en in het bijzonder in Malawi. Het begrip “triple trouble” (ofwel 
het “driedubbel drama”) van tuberculose, HIV en ondervoeding wordt uitgelegd. Dit begrip 
veronderstelt dat HIV én tuberculose én ondervoeding tezamen, grotere gezondheidsrisico’s 
veroorzaken dan wanneer slechts één van de drie aanwezig is.  Dit hoofdstuk geeft ook 
informatie over Malawi en de plaats waar de onderzoeken zijn uitgevoerd. 
 
In Hoofdstuk 2 wordt een literatuuronderzoek gepresenteerd, waarin de actuele kennis 
over de voedingstoestand van patiënten met tuberculose en HIV-co-infectie beschreven wordt. 
Veranderingen in voedingstoestand tijdens de behandeling voor tuberculose en de samenhang 
tussen voedingstoestand en het ziekteverloop worden beschreven. Verschillende onderzoeken 
beschrijven dat patiënten met tuberculose, tekorten hebben in vitamine A, thiamine, vitamine B6, 
foliumzuur en vitamine E. Verscheidene van deze tekorten komen gemiddeld meer voor bij HIV-
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geïnfecteerde tuberculosepatiënten dan bij tuberculosepatiënten zonder HIV-co-infectie. Andere 
bevindingen zijn dat eiwit- en energietekort, en bloedarmoede vaak voorkomen bij volwassenen 
met tuberculose en HIV-infectie. Metingen tonen dat de body mass index (BMI) (het gewicht in 
kilogram gedeeld door de lengte in het kwadraat) bij volwassenen met longtuberculose lager is 
dan bij gezonde volwassenen. Uit sommige onderzoeken die gebruik maakten van bioelectrische 
impedantie analyse (BIA) (een methode die de elektrische weerstand van het lichaam meet, 
waardoor vervolgens onder andere het lichaamsvetpercentage als onderdeel van de lichaams-
samenstelling kan worden berekend), blijkt dat er geen grote verschillen in lichaams-
samenstelling zijn tussen HIV-positieve en HIV-negatieve volwassenen met longtuberculose. 
Enkele onderzoeken tonen aan dat de voedingstoestand, afgemeten aan de BMI, verbeterden 
tijdens de behandeling van tuberculose. Ook de bloedarmoede lijkt te verbeteren. De 
voedingstoestand lijkt een belangrijke bijdrage te leveren aan het ziekteverloop tijdens de 
behandeling voor tuberculose. Een aantal onderzoekingen hebben de rol van aanvullende 
voeding in de vorm van micronutriënten (vitaminen en mineralen) supplementen bij tuberculose 
en HIV onderzocht. De bevindingen van deze onderzoeken worden besproken. 
 
In Hoofdstuk 3 wordt een onderzoek naar de relatie tussen ondervoeding en 
longtuberculose gepresenteerd. We hebben onderzocht of er een verband bestaat tussen de ernst 
van ondervoeding en de ernst van longziekte. De ernst van longziekte werd bepaald met behulp 
van een klassieke methode voor het beoordelen van longfoto’s. Wij hebben 319 volwassenen 
met longtuberculose met en zonder HIV-co-infectie onderzocht en aangetoond dat er een 
onafhankelijk verband bestaat tussen BMI, vetmassa en de z.g. phase angle (een maat afgeleid 
van de BIA methode) enerzijds, en de ernst van longziekte anderzijds. De analyses waren 
gecorrigeerd voor geslacht, leeftijd en de hoeveelheid HIV in het bloed. Deze resultaten steunen 
de veronderstelling dat de ernst van longtuberculose samenhangt met de ernst van ondervoeding 
bij volwassenen met longtuberculose.  
 
In Hoofdstuk 4 wordt een onderzoek beschreven dat de veronderstelling toetst dat 
tekorten aan micronutriënten samenhangen met wasting (vermagering) en met meer actieve HIV-
infectie bij volwassenen met tuberculose. We onderzochten 801 volwassenen met 
longtuberculose en vonden bij 59% van alle volwassenen een BMI van minder dan 18.5, ofwel 
wasting.  We toonden aan dat BMI, en retinol-, caroteen- en seleniumconcentraties in het bloed 
beduidend afnamen met het toenemen van de hoeveelheid HIV in het bloed. Er waren geen 
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significante verschillen tussen HIV-negatieve en HIV-positieve volwassenen bij wie de 
hoeveelheid HIV in het bloed minder was dan 133200 virus kopieën per milliliter. Vitamine A 
tekort, gedefinieerd als retinol in het bloedplasma van minder dan 0.70 micromol per liter, werd 
bij 61% van alle volwassenen gevonden. Bij 85% werd een tekort aan zink en bij 87% van alle 
volwassenen werd een tekort aan selenium geconstateerd. We toonden aan dat er een verband is 
tussen wasting en een verhoogd risico voor tekorten aan caroteen, vitamine A and selenium. 
Deze verbanden bleken het sterkst voor patiënten met ernstige wasting, gedefinieerd als BMI van 
minder dan 16.0. De resultaten van dit onderzoek tonen aan dat er een verband is tussen wasting, 
meer actieve HIV-infectie en tekorten aan micronutriënten bij longtuberculose. 
 
In Hoofdstuk 5 wordt een onderzoek gepresenteerd waarin is onderzocht of tekorten aan 
micronutriënten, ontstekingsreactie en de hoeveelheid HIV in het bloed bijdragen aan 
bloedarmoede bij volwassenen met longtuberculose. Bij 88% van de 370 HIV-positieve, en 77% 
van de 130 HIV-negatieve volwassenen met longtuberculose werd bloedarmoede geconstateerd. 
Matig-tot-ernstige bloedarmoede (hemoglobine minder dan 80 gram per liter) werd bij 30% van 
de HIV-positieven en bij 15% van de HIV-negatieven gevonden. De meerderheid van de 
volwassenen vertoonde verhoogde Interleukin-6 (IL-6) concentraties, wat veronderstelt dat er 
sprake is van een ontstekingsreactie.  Statische analyses toonden dat de hoeveelheid HIV in het 
bloed en verlaagde seleniumconcentraties in het bloed samen hangen met matig-tot-ernstige 
bloedarmoede. De hoeveelheid HIV-, selenium- en IL-6 concentraties bleken samen te hangen 
met hemoglobineconcentraties. De resultaten van dit onderzoek tonen dat verlaagde 
seleniumconcentraties, verhoogde hoeveelheid HIV in het bloed en verhoogde IL-6 concentraties 
gerelateerd zijn aan bloedarmoede bij volwassenen met longtuberculose.  
 
In Hoofdstuk 6 wordt een onderzoek gepresenteerd naar de rol van leptine in verband 
met ondervoeding in tuberculose. Leptine, een hormoon dat door vetcellen wordt aangemaakt, 
reguleert de eetlust en ondersteunt in de afweer. Bij 500 volwassenen met longtuberculose, 
hingen lage leptineconcentraties samen met lage vetmassa, en met hoge IL-6 concentraties. 
Verlies van eetlust bleek samen te hangen met verhoogde plasma IL-6 concentraties. We zagen 
een verband tussen ernstige wasting en een verhoogde hoeveelheid HIV in het bloed. Hoewel 
leptine voornamelijk bekend is als eetlust regulerend hormoon, konden wij geen verband 
aantonen tussen leptineconcentraties en het verlies van eetlust of de mogelijk daarmee 
samengaande wasting.  De resultaten van dit onderzoek veronderstellen dat de eetlust 
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vermindering veroorzaakt door infectie hoofdzakelijk verantwoordelijk is voor de ondervoeding 
bij tuberculose. Leptine zou mogelijk wel een rol kunnen spelen in de het verband tussen 
ondervoeding en afweer. Mogelijk draagt lage leptine concentraties bij tot een slechte afloop van 
het ziekteproces in tuberculose, maar verder onderzoek is nodig om deze veronderstelling te 
toetsen. 
 
Concluderend, gebaseerd op lichaamssamenstelling en micronutriënten in het bloed, 
waren zowel HIV-positieve als HIV-negatieve volwassenen met longtuberculose ernstig 
ondervoed. Het is jammer dat wij geen groep van gezonde Malawiaanse volwassenen hadden om 
de voedingsstatus te vergelijken met die van onze patiëntengroep. Een eerder onderzoek uit 
Malawi toonde echter aan dat volwassenen met longtuberculose een beduidend lagere BMI 
hadden dan gezonde volwassenen.2 Opmerkelijk is dat de gemiddelde BMI van de 
tuberculosepatiënten in dit eerdere onderzoek vergelijkbaar is met de gemiddelde BMI van de 
tuberculosepatiënten in onze onderzoeken.  
De voedingstoestand van HIV-positieve volwassenen leek vergelijkbaar met de 
voedingstoestand van HIV-negatieve volwassenen. Echter, in een onderzoek onder 801  
tuberculosepatiënten, toonden we aan dat de voedingstoestand van HIV-negatieve volwassenen 
vergelijkbaar was met de voedingstoestand van HIV-positieve volwassenen met een geringe 
hoeveelheid HIV in het bloed, maar dat de voedingstoestand beduidend afneemt met de toename 
van HIV infectie. Bloedarmoede (wat mogelijk zowel als gevolg, als als bewijs van 
ondervoeding gezien kan worden) kwam ook aanzienlijk meer voor bij volwassenen met 
tuberculose en HIV-co-infectie. We kunnen daaruit concluderen dat co-infectie met tuberculose 
en HIV de ondervoeding verergert, vergeleken met de ondervoeding bij tuberculose-infectie 
alleen. 
In onze onderzoeken werd gebruik gemaakt van BMI en maten afgeleid van BIA-
metingen, om de lichaamssamenstelling van volwassenen met longtuberculose te illustreren. Eén 
van de voordelen van de BIA-methode boven het bepalen van BMI alleen, is dat men met BIA 
een onderscheid kan maken tussen lichaamsvet en lichaamscelmassa bij individuen. In onze 
onderzoeken was BMI echter een goede maat voor ondervoeding, en kan wellicht beschouwd 
worden als een geschikte maat voor ondervoeding in situaties met minder beschikbare middelen.  
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Het verband tussen toegenomen hoeveelheid HIV in het bloed en tekort aan 
micronutriënten was het sterkst voor selenium en caroteen. Deze waarneming kan belangrijk 
zijn, gezien eerder onderzoek een verband aantoonde tussen seleniumtekort en verhoogde sterfte 
bij HIV-geinfecteerden.3  In onze onderzoekspopulatie had 90% van de HIV-positieve 
tuberculosepatiënten een seleniumtekort. Dit is wellicht de hoogst gerapporteerde prevalentie 
van seleniumtekort bij HIV-geïnfecteerde volwassenen. Onze gegevens veronderstellen tevens 
dat er een relatie bestaat tussen seleniumtekort en bloedarmoede bij volwassenen met 
tuberculose. Naar ons weten, is dit het eerste onderzoek dat een verband heeft aangetoond tussen 
selenium- en hemoglobineconcentraties. Selenium heeft een anti-oxidatieve werking en 
seleniumtekort zou mogelijk kunnen bijdragen aan bloedarmoede door toegenomen oxidatieve 
processen, maar verder onderzoek is noodzakelijk om het verband tussen seleniumtekort en 
bloedarmoede te bevestigen. Het is nog onbekend of het verstrekken van voedingssupplementen 
met selenium het ziekteproces en sterfte bij volwassenen met longtuberculose zou kunnen 
beïnvloeden.  
Wij hebben aangetoond dat er een verband is tussen verlaagde caroteenconcentraties in het bloed 
enerzijds en meer actieve HIV-infectie en wasting anderzijds. Caroteen is één van de 
belangrijkste voedings-gerelateerde antioxidanten die in het menselijke bloed gevonden worden. 
Het is niet bekend of patiënten met longtuberculose lage caroteenconcentraties hebben 
tengevolge van toegenomen oxidatieve processen of dat deze personen eenvoudigweg de 
mogelijkheid niet hebben om genoeg caroteenrijk voedsel te consumeren. Verder onderzoek is 
nodig met betrekking tot de hoeveelheid caroteen in de voeding van volwassenen met 
longtuberculose.  
In het voorgaande hoofdstuk (de Engelstalige samenvatting) wordt een figuur 
gepresenteerd, dat de in dit proefschrift beschreven relaties die bijdragen aan ondervoeding en 
(omvang van) ziekte in tuberculose en HIV-co-infectie visualiseert. Samenvattend hebben onze 
onderzoeken aangetoond dat er een verband is tussen ondervoeding bij volwassenen met 
longtuberculose en de ernst van de longziekte; dat tekort aan micronutriënten in het bloed 
samenhangt met wasting; dat de mate van tekorten aan micronutriënten, bloedarmoede en 
wasting ernstiger zijn bij volwassenen met longtuberculose en tevens meer actieve HIV-infectie; 
en dat verlaagde seleniumconcentraties, verhoogde IL-6 concentraties en verhoogde hoeveelheid 
HIV in het bloed gerelateerd zijn aan bloedarmoede. We toonden aan dat er een verband bestaat 
tussen leptineconcentraties en de voedingstoestand en tussen leptineconcentraties en 
ontstekingsreactie in volwassenen met longtuberculose. Ons onderzoek wees dat er geen verband 
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was tussen verlies van eetlust en leptineconcentraties. Daarentegen, toonden we aan dat 
verhoogde plasma IL-6 concentraties samen hingen met verlies van eetlust, en zagen we een 
verband tussen hoge hoeveelheid HIV in het bloed en ernstige wasting. We concludeerden 
hieruit dat de eetlust vermindering veroorzaakt door infectie hoofdzakelijk verantwoordelijk lijkt 
te zijn voor de ondervoeding bij tuberculose. Verder onderzoek is nodig om een beter inzicht te 
krijgen in de mechanismen die een rol spelen bij ondervoeding, evenals het effect van 
ondervoeding in relatie tot immuniteit en ziekteverloop bij tuberculose. 
De resultaten uit onze onderzoeken dragen bij tot een beter begrip over de met tuberculose 
gepaard gaande ondervoeding. Echter, de cross-sectionele opzet van de onderzoeken die in dit 
proefschrift zijn beschreven, beperkt onze conclusies en geeft geen informatie over verbanden 
tussen voedingstoestand en (re) activering van (latente) tuberculose-infectie, noch of een slechte 
voedingstoestand voorspellend is voor een ernstiger ziekteproces. Verdere longitudinale 
onderzoeken zijn nodig om deze verbanden te onderzoeken.  
Rekening houdend dat Malawi één van de armste landen in Afrika is, is de slechte 
voedingstoestand van deze zieke en arme patiëntenpopulatie mogelijk eveneens het gevolg van 
ontoereikend voedsel. De schakel tussen tuberculose, HIV, ondervoeding én armoede moet niet 
worden onderschat. Ondervoeding, als gevolg van armoede, kan het risico op (verergeren van) 
HIV-infectie vergroten, wat indirect de kans vergroot dat latente tuberculose actieve tuberculose 
wordt.4,5  
In onze onderzoekspopulatie waren zowel HIV-positieve als HIV-negatieve volwassenen 
met longtuberculose ernstig ondervoed. Tekorten aan micronutriënten en wasting, lage 
leptineconcentraties, een verlaagde immuniteit, bloedarmoede en toegenomen oxidatieve 
processen kunnen een toename van ziekte en sterfte veroorzaken. Het is niet bekend of het geven 
van voedingssupplementen de voedingstoestand en het ziekteverloop van patiënten met 
tuberculose kunnen beïnvloeden. Volwassenen met longtuberculose en meer actieve HIV-
infectie vormen de groep met het hoogste risico voor ernstige tekorten aan micronutriënten. Dit 
veronderstelt dat deze subgroep het meest baat zou kunnen hebben bij voedingsinterventies. Het 
placebo-gecontroleerd klinisch onderzoek, dat momenteel nog gaande is in onze 
patiëntenpopulatie, zal verder inzicht verschaffen over het effect van 
micronutriëntensupplementen op de voedingstoestand en het klinisch verloop van ziekte bij 
volwassenen met longtuberculose. 
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